{"gene":"RAD9A","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1988,"finding":"RAD9 gene product is essential for G2 cell cycle arrest in response to DNA damage in S. cerevisiae; rad9 mutant cells fail to delay division after irradiation and die, whereas wild-type cells arrest in G2 until damage is repaired.","method":"Genetic analysis of rad9 mutants, X-ray irradiation, cell cycle analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — foundational genetic epistasis with clean loss-of-function phenotype, replicated across multiple conditions and cell cycle phases, independently confirmed by multiple subsequent studies","pmids":["3291120"],"is_preprint":false},{"year":1990,"finding":"RAD9-dependent G2 arrest and recovery from arrest can occur in the presence of cycloheximide, demonstrating the mechanism is posttranslational; rad9 null mutants are viable but show elevated spontaneous chromosome loss.","method":"Cycloheximide treatment, deletion mutant construction, chromosome loss assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct pharmacological and genetic experiments establishing posttranslational mechanism, replicated across conditions","pmids":["2247073"],"is_preprint":false},{"year":1993,"finding":"RAD9 checkpoint is phase-specific (late S/G2) and signal-specific (DNA lesions), and RAD17 is also required for the same checkpoint; both genes are required for G2 arrest after X- or UV-irradiation.","method":"Genetic epistasis with cdc mutants, cell cycle analysis, double-mutant analysis","journal":"Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis across multiple cdc mutants and radiation conditions, replicated","pmids":["8514150"],"is_preprint":false},{"year":1993,"finding":"RAD9 is required for DNA damage-induced G1 arrest (G1/S checkpoint) in S. cerevisiae, in addition to its known G2 checkpoint role.","method":"Alpha-factor G1 synchronization, UV/gamma-irradiation, cell cycle analysis in rad9 mutants","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean loss-of-function with specific cell cycle phenotype, replicated by other labs","pmids":["8367452"],"is_preprint":false},{"year":1996,"finding":"RAD9 is required for DNA damage-dependent transcriptional induction of a large regulon of repair, replication, and recombination genes; this transcriptional response is cell cycle-independent.","method":"Northern blot analysis, lacZ reporter assays, RAD9 deletion mutants","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple methods (Northern blot, reporter assays) in single lab demonstrating RAD9-dependent transcriptional regulation","pmids":["8670896"],"is_preprint":false},{"year":1996,"finding":"RAD9 and DNA polymerase epsilon (POL2) function in parallel sensory branches upstream of Rad53 for transducing the UV DNA damage checkpoint signal; both branches independently activate Mec1/Rad53.","method":"Genetic epistasis, Rad53 phosphorylation assays, RNR3 induction assays in double mutants","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with biochemical readout (Rad53 phosphorylation) across multiple mutant combinations","pmids":["8895664"],"is_preprint":false},{"year":1997,"finding":"RAD9, RAD17, and RAD24 are required for S-phase regulation (slowing of S-phase progression) in response to alkylation damage in S. cerevisiae, acting upstream of MEC1 and RAD53.","method":"S-phase progression assays, epistasis analysis with mec1 and rad53 mutants","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis with clear S-phase readout but single lab","pmids":["9017389"],"is_preprint":false},{"year":1998,"finding":"Rad9 is hyperphosphorylated in response to DNA damage in a MEC1- and TEL1-dependent manner in S. cerevisiae; hyperphosphorylated Rad9 physically associates with Rad53 after damage.","method":"Phosphatase treatment, Western blot, co-immunoprecipitation, checkpoint gene epistasis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP with biochemical validation of phosphorylation dependency, replicated by multiple labs","pmids":["9755168"],"is_preprint":false},{"year":1998,"finding":"The C-terminal FHA domain of Rad53 specifically recognizes phosphorylated Rad9; this interaction is required for DNA damage-dependent Rad53 phosphorylation and G2/M checkpoint arrest in S. cerevisiae.","method":"FHA domain mutagenesis, co-immunoprecipitation, checkpoint functional assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — FHA domain mutagenesis with functional readouts (checkpoint arrest, Rad53 phosphorylation), replicated and extended by multiple labs","pmids":["9657725"],"is_preprint":false},{"year":1998,"finding":"RAD9 and RAD24 define two additive, interacting branches of the DNA damage checkpoint pathway upstream of MEC1 and RAD53; the double rad9Δ-rad24Δ mutant abolishes the G1/S checkpoint and essentially eliminates transcriptional damage response.","method":"Double-mutant epistasis, checkpoint delay assays, transcriptional induction assays, Rad53 modification analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (genetic, biochemical) establishing pathway position","pmids":["9564050"],"is_preprint":false},{"year":1999,"finding":"Human Rad9, Rad1, and Hus1 form a DNA damage-responsive heterotrimeric protein complex; hRad9 is phosphorylated in response to DNA damage.","method":"Co-immunoprecipitation of human proteins, DNA damage treatment","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP demonstrating complex formation, replicated by other labs","pmids":["9872989"],"is_preprint":false},{"year":1999,"finding":"The BRCT domain of yeast Rad9 mediates Rad9-Rad9 homo-oligomerization, preferentially interacting with hyperphosphorylated Rad9; BRCT mutations abolish Rad9 hyperphosphorylation, Rad53 phosphorylation, and checkpoint function.","method":"Two-hybrid, in vitro and in vivo co-immunoprecipitation, BRCT point mutagenesis, checkpoint survival assays","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — mutagenesis combined with biochemical and functional validation in single lab using multiple methods","pmids":["10339432"],"is_preprint":false},{"year":2000,"finding":"Structure predictions indicate Rad9, Rad1, and Hus1 each share a PCNA-like fold and form a heterotrimeric ring analogous to the PCNA sliding clamp; Rad17 has RFC-like ATPase clamp-loader properties.","method":"Computational fold recognition, comparative modeling, generalized sequence profiles","journal":"Nucleic acids research","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction only, no experimental validation in this paper","pmids":["10871397"],"is_preprint":false},{"year":2000,"finding":"S. pombe Hus1 forms a stable complex with Rad9 and Rad1 in vivo; Hus1 nuclear localization depends on Rad17.","method":"Co-immunoprecipitation, fractionation, indirect immunofluorescence","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (co-IP, localization) in single lab","pmids":["10648611"],"is_preprint":false},{"year":2000,"finding":"Human RAD9 interacts with the anti-apoptotic proteins BCL-2 and BCL-xL (but not pro-apoptotic BAX/BAD) and overexpression induces apoptosis that can be blocked by BCL-2 or BCL-xL; antisense RAD9 suppresses DNA damage-induced cell death.","method":"Yeast two-hybrid, co-immunoprecipitation, overexpression in mammalian cells, antisense knockdown","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus functional gain/loss-of-function experiments, replicated","pmids":["10620799"],"is_preprint":false},{"year":2000,"finding":"Solution structure of Rad53 FHA1 domain determined; a phospho-Thr peptide from Rad9 (pThr-192, motif pTXXD) binds FHA1 with Kd ~0.36 μM, identifying the molecular basis for Rad9-Rad53 interaction.","method":"NMR structure determination, peptide library screening, surface plasmon resonance","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with binding quantification, identifies specific phosphorylation site","pmids":["11124038"],"is_preprint":false},{"year":2001,"finding":"Yeast Rad9 forms two distinct large complexes: a >850 kDa complex with hypophosphorylated Rad9 in undamaged cells, and a 560 kDa complex with hyperphosphorylated Rad9 and Rad53 after damage. The 560 kDa complex catalyzes Rad53 activation via Rad53 in trans autophosphorylation (scaffold mechanism); this requires Rad53 kinase activity but not Mec1/Tel1 once the complex forms.","method":"Gel filtration, co-immunoprecipitation, in vitro kinase reconstitution assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution of Rad53 activation by purified Rad9 complex with multiple orthogonal methods","pmids":["11511366"],"is_preprint":false},{"year":2001,"finding":"In S. pombe, the Hus1-Rad1-Rad9 complex has PCNA-like structural and functional features; mutations designed using the PCNA alignment identify functionally important residues, though the complex also has unique features distinct from PCNA.","method":"Structure-function mutagenesis, checkpoint assays in fission yeast","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis-based functional validation, single lab","pmids":["11739777"],"is_preprint":false},{"year":2002,"finding":"Human Rad17 recruits the Rad9 complex (9-1-1) onto chromatin after DNA damage; Rad17 binds chromatin prior to damage and is phosphorylated by ATR on chromatin after damage; Rad17 phosphorylation is not required for Rad9 loading; Hus1 is required for damage-induced Rad17 phosphorylation.","method":"Chromatin fractionation, co-immunoprecipitation, kinase inhibition, siRNA knockdown","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — chromatin fractionation with multiple genetic/biochemical controls, replicated by multiple labs","pmids":["11799063"],"is_preprint":false},{"year":2002,"finding":"Multiple Mec1/Tel1 consensus [S/T]Q sites within yeast Rad9 are phosphorylated in response to DNA damage; these Rad9 phosphorylation sites are selectively required for Rad53 (not Chk1) branch activation; phospho-Rad9 peptides bind Rad53 FHA domains in vitro.","method":"Site-directed mutagenesis of SQ sites, in vitro FHA domain pulldown with phosphopeptides, checkpoint functional assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with in vitro binding and in vivo functional assays","pmids":["12049741"],"is_preprint":false},{"year":2002,"finding":"Electron microscopy of reconstituted human 9-1-1 complex reveals a ring structure indistinguishable in shape and size from PCNA; Rad17-RFC forms an oval clamp-loader complex with ATPase activity and binds Rad9-1-1.","method":"Baculovirus reconstitution, electron microscopy, native molecular mass determination, ATPase assay","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct structural visualization by EM of reconstituted complex with biochemical characterization","pmids":["12167163"],"is_preprint":false},{"year":2002,"finding":"c-Abl tyrosine kinase constitutively binds Rad9 via its SH3 domain interacting with the Rad9 C-terminal region; c-Abl phosphorylates Rad9 at Tyr-28 (BH3 domain) in vitro and in cells exposed to DNA damage, inducing Rad9 binding to Bcl-xL and contributing to apoptosis.","method":"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis (Tyr-28), apoptosis assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and functional co-IP, single lab","pmids":["11971963"],"is_preprint":false},{"year":2002,"finding":"Genotoxin-induced 9-1-1 chromatin binding does not require Rad9 Ser-272 phosphorylation, DNA replication, or ATM/ATR/DNA-PK catalytic activity, indicating chromatin binding is a proximal, kinase-independent event in checkpoint signaling.","method":"Chromatin fractionation, PIKK inhibitors, phosphorylation site mutants, replication inhibitors","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological and genetic controls, single lab with multiple orthogonal methods","pmids":["12228248"],"is_preprint":false},{"year":2003,"finding":"Protein kinase Cδ (PKCδ) associates with human Rad9 and phosphorylates it in vitro and in cells after genotoxic stress; PKCδ activation is required for formation of the Rad9-Hus1-Rad1 complex and for Rad9 binding to Bcl-2; inhibition of PKCδ attenuates Rad9-mediated apoptosis.","method":"Co-immunoprecipitation, in vitro kinase assay, PKCδ inhibitor, checkpoint/apoptosis assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus co-IP and functional consequences, single lab","pmids":["12628935"],"is_preprint":false},{"year":2003,"finding":"Phosphorylation of Rad9 C-terminal tail residues (beyond Ser-272) is essential for Chk1 activation following HU, IR, and UV treatment; the Rad9 phospho-tail drives S-phase checkpoint arrest; cells with phosphorylation-deficient Rad9 are as UV/HU sensitive as Rad9-null cells.","method":"Site-directed mutagenesis of nine phosphorylation sites, complementation of Mrad9-/- ES cells, checkpoint assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis with functional complementation in null cells across multiple damage types","pmids":["12709442"],"is_preprint":false},{"year":2004,"finding":"Human RAD9 can directly bind a p53 consensus DNA-binding sequence in the p21 promoter and transactivate p21 transcription; RAD9 overexpression increases p21 RNA and protein levels.","method":"Luciferase reporter assay, EMSA, overexpression, Northern blot, microarray","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus reporter assays demonstrating direct DNA binding and transactivation, single lab","pmids":["15184659"],"is_preprint":false},{"year":2004,"finding":"The 9-1-1 complex physically interacts with DNA polymerase beta in vitro and stimulates its activity, increasing affinity for primer-template and stimulating displacement synthesis; this effect is specific to Pol beta and not Pol lambda, Pol alpha, or Pol delta.","method":"In vitro pulldown, DNA polymerase activity assays, gel shift assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution with specificity controls across multiple polymerases","pmids":["15314187"],"is_preprint":false},{"year":2004,"finding":"The 9-1-1 complex binds and stimulates Flap Endonuclease 1 (FEN1) on flap, nick, and gapped substrates; stimulation is distinct from PCNA stimulation and cannot substitute for PCNA in stimulating Pol beta.","method":"In vitro binding assay, FEN1 nuclease activity assays on multiple substrates","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with multiple substrates and mechanistic dissection, replicated by other labs","pmids":["15556996"],"is_preprint":false},{"year":2004,"finding":"Mammalian Rad9 deletion sensitizes cells to camptothecin, etoposide, and cytarabine; Rad9 is required for cytarabine-induced S-phase checkpoint but not for camptothecin/etoposide S-phase checkpoint; Rad9's predominant role in ES cells is promoting survival after replication stress.","method":"Rad9-/- ES cells, clonogenic survival, S-phase checkpoint assays ([3H]thymidine incorporation, Cdc25A), apoptosis assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout with multiple readouts, single lab","pmids":["14988409"],"is_preprint":false},{"year":2004,"finding":"A specific N-terminal domain of yeast Rad9 (Chk1 activation domain, CAD) is required for Chk1 phosphorylation/activation but not for Rad53 activation, demonstrating that Rad9 activates Rad53 and Chk1 through separable domains.","method":"Rad9 domain deletion analysis, Chk1 and Rad53 phosphorylation assays, checkpoint functional assays","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mutagenesis with specific kinase readouts, single lab","pmids":["14709724"],"is_preprint":false},{"year":2004,"finding":"Mec1 phosphorylates Rad9 at S/TQ motifs in vitro and promotes Rad9 accumulation at double-strand breaks (DSBs) in vivo; multiple SQ motif mutations reduce Rad9 association with DSBs; Rad9 association with DSBs is required for full Rad9 phosphorylation and Rad9-Rad53 interaction.","method":"ChIP assay, in vitro kinase assay (Mec1), mec1 mutants, SQ motif mutagenesis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with in vivo ChIP validation and mutagenesis, single lab","pmids":["15060150"],"is_preprint":false},{"year":2004,"finding":"Mouse Rad9 (Mrad9) deletion causes embryonic lethality at midgestation; Mrad9-/- cells show increased chromosome aberrations, HPRT mutations, and extreme sensitivity to UV, gamma rays, and hydroxyurea; ectopic expression of Mrad9 or human HRAD9 complements these defects.","method":"Targeted gene deletion, embryonic stem cell analysis, clonogenic survival, mutation frequency, complementation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with multiple phenotypic readouts and complementation, independent of checkpoint analysis","pmids":["15282322"],"is_preprint":false},{"year":2005,"finding":"Dot1-dependent methylation of histone H3 Lys79 is required for Rad9 binding to DSBs and for Rad53 phosphorylation in G1 and S-phase checkpoints; mutation of the Rad9 Tudor domain (responsible for binding methylated H3K79) phenocopies the dot1Δ checkpoint defect.","method":"Checkpoint assays in dot1Δ/H3K79 mutants, Rad9 Tudor domain mutagenesis, Rad53 phosphorylation, DSB binding assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with mechanistic link to histone modification and Rad9 Tudor domain mutagenesis","pmids":["16166626"],"is_preprint":false},{"year":2005,"finding":"Yeast Rad9 acts as a bona fide signaling adaptor (not scaffold) that enables efficient, direct phosphorylation of Rad53 by Mec1 through a phospho- and FHA-dependent Rad9-Rad53 interaction; Rad9 stimulates Mec1 to phosphorylate Rad53 in biochemical reconstitution.","method":"Biochemical reconstitution with purified Rad9, Rad53 phosphorylation mapping by mass spectrometry, in vitro kinase assays","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution with purified components, mass spectrometry-based phosphosite mapping","pmids":["16085488"],"is_preprint":false},{"year":2005,"finding":"RAD9-Hus1-Rad1 (9-1-1) interacts with RPA in human cells; Rad9 binds both RPA70 and RPA32 subunits; UV/camptothecin stimulate 9-1-1/RPA interaction; RPA siRNA knockdown blocks damage-dependent chromatin association of 9-1-1 and 9-1-1 complex formation.","method":"Co-immunoprecipitation, siRNA knockdown, nuclear focus colocalization, chromatin fractionation","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (co-IP, siRNA, chromatin fractionation) in single lab","pmids":["15897895"],"is_preprint":false},{"year":2006,"finding":"Mammalian Rad9 interacts with Rad51; Mrad9 inactivation leads to increased telomere end-to-end associations, telomere loss, delayed gamma-H2AX focus kinetics, and reduced homologous recombination repair, indicating a role in HR and telomere stability.","method":"Co-immunoprecipitation, HR repair assays, telomere FISH, gamma-H2AX focus analysis, Rad9 conditional knockdown","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus multiple functional assays, single lab","pmids":["16479004"],"is_preprint":false},{"year":2006,"finding":"The 9-1-1 complex (via Rad9 and Hus1 individually and as complex) interacts with and stimulates NEIL1 DNA glycosylase activity; Rad9 and NEIL1 colocalize to nuclear foci in H2O2-treated cells.","method":"Co-immunoprecipitation, in vitro glycosylase stimulation assay, immunofluorescence co-localization","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro biochemical stimulation plus in vivo co-IP and co-localization, single lab","pmids":["17395641"],"is_preprint":false},{"year":2006,"finding":"The mammalian 9-1-1 complex localizes to telomeres and associates with catalytically competent telomerase; Hus1-deficient cells show severe telomere shortening; 9-1-1 positively regulates telomerase DNA polymerase activity.","method":"Telomere length measurement (Q-FISH), telomerase activity assay, co-immunoprecipitation with telomerase","journal":"Current biology : CB","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (FISH, telomerase assay, co-IP) in single lab demonstrating telomeric role","pmids":["16890531"],"is_preprint":false},{"year":2007,"finding":"Rad9's role in Chk1 activation is to recruit TopBP1 to the replication fork; the 9-1-1 clamp's primary function is to localize the ATR-activating domain (AD) of TopBP1 via direct Rad9-TopBP1 binding; fusion of AD to PCNA or H2B bypasses the 9-1-1 requirement.","method":"Co-immunoprecipitation, domain fusion experiments, Chk1 phosphorylation assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic bypass experiment (AD fusion to PCNA/H2B) plus co-IP defines functional mechanism, replicated","pmids":["17575048"],"is_preprint":false},{"year":2007,"finding":"In Xenopus egg extracts, the C-terminal domain of Rad9 interacts with BRCT I-II of TopBP1 via phosphorylation of Ser-373; this interaction is required for ATR-ATRIP binding to TopBP1's activating domain and for checkpoint signaling; Rad9 Ser-373-Ala and TopBP1 ΔBRCT I-II mutants are checkpoint defective.","method":"Xenopus egg extract biochemistry, co-immunoprecipitation, phospho-mutant analysis, Rad9 C-terminal fragment inhibitor","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in egg extracts with phosphosite mutagenesis, domain deletion, and functional inhibitor","pmids":["17636252"],"is_preprint":false},{"year":2007,"finding":"Rad9 BRCT domain directly interacts with phosphorylated histone H2A in vitro; a Rad9 point mutation abolishing this interaction causes G1 checkpoint defects similar to H2A phosphorylation site mutation; the Tudor domain mediates constitutive chromatin association while BRCT domain-pH2A interaction enables damage-specific G1 arrest.","method":"In vitro BRCT-phospho-H2A binding assay, point mutagenesis, G1 checkpoint assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro direct binding with mutagenesis and matching in vivo phenotype","pmids":["17721446"],"is_preprint":false},{"year":2007,"finding":"The Rad9 Tudor domain binds to histone H3 methylated at Lys79 (H3K79me) in vitro and is required for Rad9 focal accumulation after DNA damage; Tudor-H3K79me interaction functions in G1 checkpoint activation and G2 DSB repair.","method":"In vitro Tudor domain-H3K79me binding assay, Rad9 Tudor mutants, checkpoint assays, focus formation","journal":"Yeast (Chichester, England)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro histone modification binding plus in vivo mutant phenotypes, consistent with other labs' findings","pmids":["17243194"],"is_preprint":false},{"year":2007,"finding":"The 9-1-1 complex interacts with and stimulates human TDG glycosylase; Rad9-TDG interaction is enhanced after MNNG treatment; Hus1 binding domain mapped to TDG residues 67-110.","method":"Co-immunoprecipitation, glycosylase activity assay, domain mapping mutagenesis, co-localization","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical stimulation assay plus co-IP and domain mapping, single lab","pmids":["17855402"],"is_preprint":false},{"year":2007,"finding":"The 9-1-1 complex interacts with APE1 in vitro and in vivo and stimulates APE1 AP-endonuclease activity; the 9-1-1 complex enhances long-patch base excision repair (LP-BER) reconstituted in vitro by specifically stimulating APE1 and Pol beta.","method":"In vitro co-immunoprecipitation, APE1 endonuclease assay, LP-BER reconstitution assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution of LP-BER with mechanistic hierarchy established","pmids":["17426133"],"is_preprint":false},{"year":2008,"finding":"Dot1 histone methyltransferase and Rad9 (via Tudor domain binding to H3K79me) inhibit DNA end resection at DSBs and uncapped telomeres; loss of Rad9 or Dot1 leads to faster ssDNA accumulation at DSBs via a Rad50-dependent nuclease, accelerating Mec1 activation.","method":"ssDNA quantification (QAOS), genetic analysis of dot1Δ and rad9 mutants, DSB resection kinetics","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — quantitative ssDNA assay with genetic dissection and multiple controls","pmids":["18418382"],"is_preprint":false},{"year":2008,"finding":"The basic cleft of RPA70 N-terminal OB-fold domain binds RAD9 via an acidic peptide in the RAD9 C-terminal tail (checkpoint recruitment domain, CRD); mutation of the RAD9 CRD impairs its localization to damage sites without affecting 9-1-1 complex formation or TopBP1 binding; RAD9-RPA interaction is required for ATR signaling to CHK1.","method":"Domain mutagenesis, co-immunoprecipitation, nuclear focus formation assays, Chk1 phosphorylation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — domain mutagenesis with multiple specific functional readouts, single lab","pmids":["18936170"],"is_preprint":false},{"year":2008,"finding":"TLK1B phosphorylates human Rad9 at S328; TLK1B overexpression hastens DSB repair and modulates the amount of 9-1-1 at DSBs; Rad9 competes with chromatin assembly factor Asf1 for TLK1B binding.","method":"In vitro kinase assay, co-immunoprecipitation, ChIP at HO-induced DSB, complementation in Rad9-null cells","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus in vivo ChIP and functional complementation, single lab","pmids":["18940270"],"is_preprint":false},{"year":2008,"finding":"Rad9 plays a role in DNA mismatch repair through direct physical interaction with MLH1; a single-point mutation in Rad9 disrupting MLH1 interaction significantly reduces MMR activity without affecting checkpoint functions.","method":"Co-immunoprecipitation, MMR activity assay, single-point mutagenesis, checkpoint assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specific mutagenesis dissecting MMR from checkpoint function, single lab","pmids":["18842633"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of human 9-1-1 complex determined at 3.2 Å (Doré et al.) and at 2.5 Å (Sohn and Cho); the complex forms a toroidal heterotrimeric ring similar to PCNA with a single repair enzyme-binding site on 9-1-1 that can be competitively blocked by p21(cip1/waf1); FEN1 PIP box binds to the IDC loop of Rad1.","method":"X-ray crystallography, biochemical competition assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures from two independent labs, biochemical validation of binding sites","pmids":["19446481","19464297"],"is_preprint":false},{"year":2009,"finding":"TLK1B promotes repair of DSB ends with incompatible termini through its interaction with Rad9; Rad9 is important for processing ends prior to ligation; TLK1B's kinase activity is required for timely release of Rad17 and Rad9 from the DSB after repair.","method":"In vitro plasmid ligation assay, Rad9 immunodepletion, HO-cleavage system, ChIP","journal":"BMC molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical end-joining assay with depletion and ChIP, single lab","pmids":["20021694"],"is_preprint":false},{"year":2010,"finding":"Crystal structure of the N-terminal region of human TopBP1 reveals a triple-BRCT domain; pSer387 of Rad9 (phosphorylated by CK2) specifically interacts with the second (but not third) BRCT domain of TopBP1.","method":"X-ray crystallography, phosphopeptide binding assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with defined phosphopeptide binding specificity","pmids":["20724438"],"is_preprint":false},{"year":2010,"finding":"Casein kinase 2 (CK2) phosphorylates Rad9 at Ser-341 and Ser-387 in the C-terminal tail; phosphorylation at both sites is required for efficient interaction with TopBP1 in vitro; CK2 phosphorylation is required in vivo and cells expressing phospho-deficient Rad9 are hypersensitive to UV and MMS.","method":"In vitro kinase assay with CK2, site-directed mutagenesis, co-immunoprecipitation, clonogenic survival","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and functional in vivo validation","pmids":["20545769"],"is_preprint":false},{"year":2010,"finding":"In fission yeast, DDK (Hsk1/Cdc7) phosphorylates Rad9 in response to replication-induced DNA damage; Rad9 phosphorylation by DDK is dependent on prior Rad3(ATR) phosphorylation and disrupts Rad9-RPA interaction, promoting release of Rad9 from DNA damage sites to facilitate repair.","method":"Kinase assays, phosphorylation-deficient mutants, DNA repair foci assays, co-immunoprecipitation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — kinase-substrate relationship established in vitro and in vivo with mechanistic consequence demonstrated","pmids":["21095590"],"is_preprint":false},{"year":2010,"finding":"In S. cerevisiae, CDK1-dependent phosphorylation of Rad9 on Ser11 creates a binding site for Dpb11, enabling a chromatin-binding-independent pathway for Rad53 activation; BRCT domain-mediated Rad9 dimerization is required for chromatin binding and checkpoint function in G1 and M phases.","method":"CDK1 phosphorylation site mutagenesis, Dpb11 interaction assays, BRCT domain mutants, artificial dimerization with GST/FKBP fusions, checkpoint assays","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple mutagenesis approaches with specific pathway dissection, single lab","pmids":["20700441"],"is_preprint":false},{"year":2011,"finding":"Dpb11 forms a ternary complex with Mec1 and Rad9, required for efficient Rad9 phosphorylation by Mec1 in vitro and checkpoint activation in vivo; CDK1 phosphorylates Rad9 on two key residues, generating a Dpb11 BRCT-binding site for Rad9 recruitment into the ternary complex; this ensures checkpoint signaling is restricted to non-G1 phases.","method":"In vitro kinase assay with reconstituted ternary complex, CDK1 phosphosite mutagenesis, Dpb11 interaction assays, checkpoint assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of ternary complex with in vivo checkpoint validation and cell cycle control mechanism","pmids":["21946560"],"is_preprint":false},{"year":2011,"finding":"Human Rad9 is methylated by PRMT5 (protein arginine methyltransferase 5); arginine methylation of Rad9 is required for S/M and G2/M checkpoint activation and Chk1 activation; methylation-deficient Rad9 increases cellular sensitivity to DNA damage.","method":"Co-immunoprecipitation, in vitro methylation assay, arginine methylation site mutagenesis, Chk1 phosphorylation assays, checkpoint and survival assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro methylation assay plus functional mutagenesis, single lab","pmids":["21321020"],"is_preprint":false},{"year":2012,"finding":"DNA-repair scaffolds Slx4 and Rtt107 prevent hyperactivation of checkpoint signaling by competing with the Rad9 adaptor; Slx4-Rtt107 complex physically interacts with Dpb11 and phospho-H2A, thereby reducing Rad9-dependent Rad53 activation; loss of Slx4 or Rtt107 causes Rad53 hyperactivation.","method":"Co-immunoprecipitation, epistasis with rad53/H2A hypomorphs, Rad53 phosphorylation assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mechanistic competition model with co-IP and genetic rescue, published in high-profile journal","pmids":["23160493"],"is_preprint":false},{"year":2012,"finding":"Stable reduction of Rad9 in prostate cancer cells impairs migration, invasion, and anchorage-independent growth; Rad9 promotes anoikis resistance by maintaining integrin β1 expression and Akt activation; Mrad9 expression in Rad9-knockdown cells restores these phenotypes.","method":"siRNA and stable shRNA knockdown, migration/invasion assays, anchorage-independent growth, anoikis assays, Akt activation measurements","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — stable knockdown and rescue with multiple functional readouts, single lab","pmids":["23066031"],"is_preprint":false},{"year":2013,"finding":"TLK1 phosphorylates Rad9 at Thr355 in vitro and in vivo; this phosphorylation is reduced upon ionizing radiation exposure; TLK1 depletion causes prolonged G2/M arrest after IR, phenocopied by Rad9-T355A overexpression; TLK1 and Chk1 act together to modulate Rad9 phosphorylation status.","method":"In vitro kinase assay, phospho-specific analysis, siRNA depletion, T355A mutant overexpression, cell cycle analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with in vivo phosphosite validation and functional mutant phenotype, single lab","pmids":["24376897"],"is_preprint":false},{"year":2014,"finding":"The 9-1-1/TopBP1 interaction and ATR activation create a positive feedback loop: 9-1-1 and TopBP1 independently recruit to UV-damage sites, then direct interaction of phospho-Rad9 with TopBP1 activates ATR, which in turn promotes further TopBP1 accumulation at damage sites.","method":"Laser UV-microirradiation, live-cell focus analysis, TopBP1-binding-deficient Rad9 mutant, ATR kinase inhibitor","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutant and pharmacological dissection of sequential events in cells, single lab","pmids":["25091155"],"is_preprint":false},{"year":2015,"finding":"Yeast Rad9 limits the action of Sgs1/Dna2 at DSBs by inhibiting Sgs1 binding at DSB ends; deletion of RAD9 reduces Mre11 binding to DSBs and restores DSB end-tethering and efficient repair in cells lacking Sae2 or with nuclease-deficient MRX.","method":"ChIP at HO-induced DSB, genetic epistasis with sgs1-ss mutant, DSB repair assays","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with genetic epistasis in multiple mutant combinations, single lab","pmids":["25637499"],"is_preprint":false},{"year":2015,"finding":"Rad9 (yeast 53BP1 ortholog) promotes Mre11 retention at persistent DSBs; deletion of RAD9 reduces Mre11 binding, facilitates Rad52 recruitment, and restores end-tethering and repair via an Sgs1-dependent mechanism in sae2Δ cells.","method":"ChIP, genetic epistasis, DSB repair and end-tethering assays","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and genetic analysis in multiple mutant backgrounds, single lab","pmids":["25569305"],"is_preprint":false},{"year":2018,"finding":"Sae2 counteracts Rad9 accumulation at DSBs by competing for Tel1 phosphorylation substrates, thereby reducing Rad9 binding to chromatin and to Rad53; this function is independent of Mre11 nuclease activity.","method":"ChIP at DSBs, epistasis analysis, Rad53 phosphorylation assays, Tel1 substrate competition analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and biochemical analysis with genetic dissection, single lab","pmids":["30510002"],"is_preprint":false},{"year":2018,"finding":"Mrc1 and Rad9 control DNA replication through complementary mechanisms: Mrc1 rapidly activates Rad53 at stalled forks to repress late-firing origins, while Rad9 takes over to maintain sustained checkpoint signaling; Rad9-mediated Rad53 activation slows fork progression.","method":"DNA combing, origin firing analysis, Rad53 phosphorylation kinetics, genetic epistasis between mrc1 and rad9 mutants","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — DNA combing with genetic analysis in single lab demonstrating distinct mechanisms","pmids":["30158111"],"is_preprint":false},{"year":2003,"finding":"Caspase-3 cleaves human Rad9 at multiple sites; cleavage results in translocation of the N-terminal BH3-containing fragment from nucleus to cytosol, where it binds Bcl-XL and promotes apoptosis; cleavage-resistant Rad9 DDD/AAA mutant protects cells from DNA damage-induced apoptosis.","method":"In vitro caspase-3 cleavage assay, site-directed mutagenesis, caspase inhibitors, caspase-3-deficient MCF-7 cells, immunofluorescence, apoptosis assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro cleavage reconstitution with mutagenesis and cell-based validation, mechanistic consequence demonstrated","pmids":["14508514"],"is_preprint":false}],"current_model":"RAD9A (human RAD9) encodes the RAD9 subunit of the heterotrimeric 9-1-1 (RAD9-HUS1-RAD1) PCNA-like sliding clamp, which is loaded onto RPA-coated ssDNA at damage sites by the RAD17-RFC clamp loader; once loaded, the clamp recruits TopBP1 via CK2-phosphorylated Ser-341/Ser-387 in the RAD9 C-terminal tail, which in turn activates the ATR-ATRIP kinase complex to phosphorylate CHK1, driving S-phase and G2/M checkpoints; additionally, RAD9 acts as a scaffold/adaptor that directly stimulates multiple base-excision repair enzymes (FEN1, APE1, Pol β, NEIL1, TDG, MYH), participates in homologous recombination and mismatch repair (via MLH1), undergoes regulatory phosphorylation by PKCδ, c-Abl (Tyr-28), TLK1 (Ser-328/Thr-355), and is cleaved by caspase-3 to release a pro-apoptotic BH3-containing N-terminal fragment that antagonizes BCL-2/BCL-xL; chromatin recruitment is governed by Dot1-methylated H3K79 binding via the Tudor domain and phospho-H2AX recognition by the BRCT domains."},"narrative":{"mechanistic_narrative":"RAD9A encodes the RAD9 subunit of the heterotrimeric 9-1-1 (RAD9-HUS1-RAD1) DNA-damage clamp and is a core sensor/transducer of the DNA damage checkpoint, originally defined in budding yeast as essential for cell-cycle arrest in G1, S, and G2 after genotoxic insult [PMID:3291120, PMID:8367452, PMID:9017389]. RAD9, RAD1, and HUS1 assemble into a toroidal heterotrimeric ring structurally indistinguishable from the PCNA sliding clamp [PMID:12167163, PMID:19446481, PMID:19464297], which is recruited onto RPA-coated damage sites by the RAD17-RFC clamp loader [PMID:11799063, PMID:15897895]. Once loaded on chromatin—a proximal, kinase-independent event [PMID:12228248]—the clamp localizes the ATR-activating domain of TopBP1 through direct binding of CK2-phosphorylated RAD9 C-terminal residues (Ser-341/Ser-387, and Ser-373 in Xenopus), driving ATR-dependent CHK1 activation and S/G2 checkpoint arrest [PMID:17575048, PMID:17636252, PMID:20724438, PMID:20545769]. In yeast the orthologous Rad9 acts as a phospho-dependent signaling adaptor that, after Mec1/Tel1 phosphorylation at S/TQ motifs, engages the Rad53 FHA domain to enable Rad53 activation [PMID:9755168, PMID:9657725, PMID:11124038, PMID:12049741, PMID:16085488]; its chromatin recruitment is governed by the Tudor domain binding Dot1-methylated H3K79 and the BRCT domains recognizing phospho-H2A/oligomerizing RAD9 [PMID:10339432, PMID:16166626, PMID:17721446, PMID:17243194]. Beyond checkpoint signaling, the 9-1-1 clamp directly stimulates multiple base-excision-repair enzymes including FEN1, Pol β, APE1, NEIL1, and TDG [PMID:15314187, PMID:15556996, PMID:17395641, PMID:17855402, PMID:17426133], and RAD9 contributes to homologous recombination, telomere maintenance, and mismatch repair through interactions with RAD51, telomerase, and MLH1 [PMID:16479004, PMID:16890531, PMID:18842633]. RAD9 also has a pro-apoptotic function: it binds and antagonizes BCL-2/BCL-xL, and caspase-3 cleavage releases a BH3-containing N-terminal fragment that translocates to the cytosol to promote apoptosis [PMID:10620799, PMID:14508514]. Genetic deletion of mouse Rad9 causes midgestation embryonic lethality, genomic instability, and hypersensitivity to genotoxins, establishing its essential role in genome maintenance [PMID:15282322].","teleology":[{"year":1988,"claim":"Established that RAD9 is required for cell-cycle arrest after DNA damage, defining the existence of a damage checkpoint dependent on a dedicated gene rather than the repair machinery itself.","evidence":"Genetic analysis of rad9 mutants with X-irradiation and cell cycle analysis in S. cerevisiae","pmids":["3291120"],"confidence":"High","gaps":["No molecular function or biochemical activity assigned","Checkpoint mechanism downstream of RAD9 unknown"]},{"year":1993,"claim":"Extended RAD9 checkpoint function to G1/S and S-phase and placed it genetically with RAD17/RAD24 upstream of MEC1/RAD53, mapping its position in the checkpoint hierarchy.","evidence":"Genetic epistasis, cell-cycle synchronization, and double-mutant analysis across radiation conditions in yeast","pmids":["8514150","8367452","9017389","9564050"],"confidence":"High","gaps":["Biochemical nature of the signal transduced unknown","Did not establish whether RAD9 acts as enzyme, adaptor, or structural component"]},{"year":1996,"claim":"Showed RAD9 controls a damage-induced transcriptional regulon and defines a sensory branch parallel to Pol epsilon, broadening its role beyond simple cell-cycle arrest.","evidence":"Northern blots, lacZ reporters, and genetic epistasis with Rad53 phosphorylation readouts in yeast deletion mutants","pmids":["8670896","8895664"],"confidence":"High","gaps":["Mechanism linking RAD9 to transcription not resolved","Direct vs indirect transcriptional role unclear"]},{"year":1998,"claim":"Identified RAD9 as a phospho-dependent adaptor: damage-induced Mec1/Tel1 hyperphosphorylation of Rad9 creates an FHA-domain docking site for Rad53, defining the molecular link between sensor and effector kinase.","evidence":"Phosphatase treatment, co-IP, FHA domain mutagenesis, and checkpoint functional assays in yeast","pmids":["9755168","9657725","9564050"],"confidence":"High","gaps":["Specific phosphosites not yet mapped","Structural basis of FHA recognition not yet defined"]},{"year":1999,"claim":"Demonstrated that human RAD9, RAD1, and HUS1 form a damage-responsive heterotrimeric complex and that the Rad9 BRCT domain mediates phospho-dependent oligomerization required for checkpoint function.","evidence":"Co-IP of human proteins, two-hybrid, BRCT point mutagenesis, and checkpoint survival assays","pmids":["9872989","10339432"],"confidence":"High","gaps":["Architecture of the complex unknown","Whether complex resembled a clamp not yet shown"]},{"year":2000,"claim":"Predicted and began testing that 9-1-1 is a PCNA-like sliding clamp loaded by an RFC-like RAD17, reframing RAD9 as a structural DNA-binding clamp subunit; concurrently linked human RAD9 to apoptosis via BCL-2/BCL-xL.","evidence":"Computational fold recognition, fission-yeast complex co-IP/localization, NMR of Rad53 FHA1 with Rad9 phosphopeptide, and two-hybrid/co-IP with apoptosis assays","pmids":["10871397","10648611","11124038","10620799"],"confidence":"High","gaps":["Clamp model still computational/inferred at this stage","Mechanism of apoptotic function not yet defined"]},{"year":2001,"claim":"Reconstituted Rad9 as a scaffold catalyzing Rad53 activation in trans and confirmed PCNA-like structure-function features, distinguishing damage-specific from undamaged Rad9 complexes.","evidence":"Gel filtration, co-IP, in vitro kinase reconstitution, and structure-function mutagenesis in budding and fission yeast","pmids":["11511366","11739777"],"confidence":"High","gaps":["Reconciliation of scaffold vs adaptor models not yet settled","Loading mechanism onto DNA not directly visualized"]},{"year":2002,"claim":"Defined chromatin loading as a proximal, kinase-independent event mediated by RAD17 recruitment of 9-1-1, mapped Mec1/Tel1 SQ phosphosites selectively required for the Rad53 branch, and directly visualized the 9-1-1 ring by EM as PCNA-like.","evidence":"Chromatin fractionation with PIKK inhibitors, SQ-site mutagenesis with FHA pulldowns, and EM of baculovirus-reconstituted human 9-1-1 and Rad17-RFC","pmids":["11799063","12049741","12167163","12228248"],"confidence":"High","gaps":["How RPA directs loading not yet established","Atomic structure of clamp not yet available"]},{"year":2002,"claim":"Connected RAD9 to apoptotic signaling kinases, showing c-Abl phosphorylates Rad9 Tyr-28 in its BH3 domain to promote BCL-xL binding, linking the checkpoint protein to genotoxic cell-death decisions.","evidence":"Co-IP, in vitro kinase assays, Tyr-28 mutagenesis, and apoptosis assays in mammalian cells","pmids":["11971963"],"confidence":"High","gaps":["Quantitative contribution of apoptotic vs checkpoint role unclear","Single-lab phosphosite assignment"]},{"year":2003,"claim":"Identified PKCδ as a regulator of 9-1-1 assembly and Rad9-BCL-2 binding, and showed caspase-3 cleavage liberates a pro-apoptotic BH3 N-terminal fragment, establishing post-translational control of RAD9's life/death function.","evidence":"Co-IP, in vitro kinase and caspase cleavage assays, cleavage-resistant mutants, and apoptosis assays in caspase-3-deficient cells","pmids":["12628935","14508514"],"confidence":"High","gaps":["Physiological balance between cleaved and intact RAD9 pools unquantified","In vivo significance of apoptotic fragment not tested in animals"]},{"year":2003,"claim":"Demonstrated that RAD9 C-terminal tail phosphorylation drives CHK1 activation and replication-stress survival, separating the CHK1 branch determinants in the mammalian protein.","evidence":"Systematic phosphosite mutagenesis with complementation of Mrad9-/- ES cells and checkpoint assays across UV/IR/HU","pmids":["12709442"],"confidence":"High","gaps":["Identity of the kinase(s) phosphorylating the tail not yet defined","Downstream effector recruited by phospho-tail unknown"]},{"year":2004,"claim":"Established that the 9-1-1 clamp directly stimulates base-excision-repair enzymes (Pol β, FEN1), revealing a repair-promoting scaffold function distinct from PCNA and from checkpoint signaling.","evidence":"In vitro pulldowns and polymerase/nuclease activity assays with specificity controls across multiple polymerases","pmids":["15314187","15556996","15184659"],"confidence":"High","gaps":["Whether BER stimulation occurs in vivo at lesions not directly shown","Coordination with checkpoint loading unclear"]},{"year":2004,"claim":"Genetically separated the Rad53 and Chk1 activation functions of yeast Rad9 into distinct domains, mapped Mec1-driven Rad9 accumulation at DSBs by ChIP, and showed mouse Rad9 is essential for embryonic viability and genome stability.","evidence":"Domain deletion with kinase readouts, ChIP with SQ mutagenesis, and targeted Mrad9 deletion with survival/mutation/complementation assays","pmids":["14709724","15060150","15282322","14988409"],"confidence":"High","gaps":["Mechanism distinguishing Chk1 vs Rad53 branch recruitment incomplete","Cause of embryonic lethality not resolved to a single pathway"]},{"year":2005,"claim":"Defined the chromatin-recruitment code for Rad9 via Dot1-methylated H3K79 binding by the Tudor domain and RPA interaction in human cells, and clarified the adaptor mechanism enabling Mec1 to phosphorylate Rad53.","evidence":"Checkpoint assays in dot1Δ/H3K79 mutants with Tudor mutagenesis, biochemical reconstitution with mass-spec phosphomapping, and co-IP/siRNA/chromatin fractionation for RPA","pmids":["16166626","16085488","15897895"],"confidence":"High","gaps":["Relative contributions of histone marks vs RPA to recruitment not fully partitioned","Human RPA-binding interface not yet mapped at residue level"]},{"year":2006,"claim":"Extended RAD9/9-1-1 function to homologous recombination, telomere maintenance, and additional BER glycosylase stimulation, broadening the clamp's genome-maintenance roles.","evidence":"Co-IP with Rad51 and telomerase, HR and telomere FISH assays, and in vitro NEIL1 glycosylase stimulation with co-localization","pmids":["16479004","16890531","17395641"],"confidence":"Medium","gaps":["Direct vs indirect role in HR/telomere not fully dissected","Single-lab functional assignments"]},{"year":2007,"claim":"Resolved the central mechanism of CHK1 activation: 9-1-1 recruits TopBP1 via phospho-Rad9 C-terminal residues to localize the ATR-activating domain, with TopBP1 bypass by AD-PCNA/H2B fusions proving the clamp's role is positional.","evidence":"Co-IP, domain-fusion bypass, phosphosite (Ser-373) mutagenesis, and CHK1 phosphorylation assays in human cells and Xenopus extracts","pmids":["17575048","17636252","17721446","17243194","17855402","17426133"],"confidence":"High","gaps":["Kinase identity for the key C-terminal site not yet pinned (resolved later)","Stoichiometry of clamp:TopBP1:ATR not determined"]},{"year":2008,"claim":"Identified the RAD9 checkpoint recruitment domain binding the RPA70 OB-fold, revealed a resection-limiting role through Dot1/H3K79me, and characterized TLK1 and MLH1 interactions linking RAD9 to repair and mismatch repair.","evidence":"Domain mutagenesis with focus/CHK1 assays, ssDNA quantification (QAOS) with genetic dissection, and in vitro kinase/MMR assays with point mutants","pmids":["18936170","18418382","18940270","18842633"],"confidence":"High","gaps":["How resection control integrates with checkpoint signaling not fully resolved","MMR contribution single-lab and not validated in vivo"]},{"year":2009,"claim":"Solved the atomic structure of human 9-1-1, revealing a PCNA-like toroid with a single repair-enzyme-binding site competitively blocked by p21 and a FEN1 PIP-box docking on the Rad1 IDC loop.","evidence":"X-ray crystallography from two independent labs with biochemical competition assays, plus TLK1B end-joining/release assays","pmids":["19446481","19464297","20021694"],"confidence":"High","gaps":["Structure of DNA-bound or loaded clamp not captured","How enzyme handoffs at the single site are ordered unknown"]},{"year":2010,"claim":"Mapped CK2 phosphorylation of Rad9 Ser-341/Ser-387 and the TopBP1 BRCT2 docking that enable ATR activation, and identified DDK and CDK1 phosphorylation events controlling Rad9 release and cell-cycle-restricted recruitment.","evidence":"In vitro kinase assays with mutagenesis and survival assays, TopBP1 crystal structure with phosphopeptide binding, and Dpb11/CDK1 mutagenesis with checkpoint assays in yeast","pmids":["20724438","20545769","21095590","20700441"],"confidence":"High","gaps":["Integration of multiple kinase inputs on Rad9 tail not quantified","Dynamics of recruitment vs release in vivo incompletely characterized"]},{"year":2011,"claim":"Established the Dpb11-Mec1-Rad9 ternary complex requiring CDK1-generated docking sites and identified PRMT5 arginine methylation of RAD9 as a checkpoint regulator, refining how RAD9 phosphorylation by Mec1 is enabled and cell-cycle-gated.","evidence":"In vitro reconstitution of ternary complex with CDK1 phosphosite mutagenesis, and in vitro methylation assays with site mutagenesis and CHK1/checkpoint readouts","pmids":["21946560","21321020"],"confidence":"Medium","gaps":["Whether ternary complex model applies in mammals not shown","PRMT5 methylation single-lab and human-only"]},{"year":2015,"claim":"Revealed RAD9 as a negative regulator of DSB end resection by limiting Sgs1/Dna2 and retaining Mre11, identifying a counterbalancing role to its checkpoint-activating function in repair-pathway choice.","evidence":"ChIP at HO-induced DSBs with genetic epistasis and end-tethering/repair assays in yeast","pmids":["25637499","25569305"],"confidence":"Medium","gaps":["Conservation of resection-limiting role in mammals not established","Molecular basis for nuclease inhibition incomplete"]},{"year":2018,"claim":"Showed checkpoint signaling is tuned by antagonists and division of labor: Slx4/Rtt107 and Sae2 limit Rad9-driven Rad53 hyperactivation, while Mrc1 and Rad9 control replication checkpoint phases through complementary mechanisms.","evidence":"Co-IP and ChIP with genetic epistasis, Rad53 phosphorylation kinetics, and DNA combing in yeast mutants","pmids":["23160493","30510002","30158111","25091155"],"confidence":"Medium","gaps":["Whether these regulatory antagonists operate on mammalian RAD9A unknown","Quantitative thresholds for checkpoint tuning not defined"]},{"year":null,"claim":"How the multiple post-translational inputs (CK2, c-Abl, PKCδ, TLK1, CDK1, DDK, PRMT5, caspase-3) are integrated to switch RAD9A between checkpoint-activating, repair-promoting, resection-limiting, and pro-apoptotic states in human cells remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model integrating RAD9A's modifications and functional states in mammals","Structure of the loaded, DNA-bound human 9-1-1 with partners not determined","In vivo coordination of repair vs apoptotic decisions not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[8,33,38,39]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[20,48]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[25,30]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[40,41]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[26,27,43]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[4,25]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[13,18,22]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[18,30,34]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[64]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[0,3,24,38]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[26,27,43,47]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[18,38,39]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[14,64]}],"complexes":["9-1-1 (RAD9-HUS1-RAD1) clamp"],"partners":["HUS1","RAD1","TOPBP1","RPA","BCL2L1","FEN1","MLH1","RAD51"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q99638","full_name":"Cell cycle checkpoint control protein RAD9A","aliases":["DNA repair exonuclease rad9 homolog A"],"length_aa":391,"mass_kda":42.5,"function":"Component of the 9-1-1 cell-cycle checkpoint response complex that plays a major role in DNA repair (PubMed:10713044, PubMed:17575048, PubMed:20545769, PubMed:21659603, PubMed:31135337). The 9-1-1 complex is recruited to DNA lesion upon damage by the RAD17-replication factor C (RFC) clamp loader complex (PubMed:21659603). Acts then as a sliding clamp platform on DNA for several proteins involved in long-patch base excision repair (LP-BER) (PubMed:21659603). The 9-1-1 complex stimulates DNA polymerase beta (POLB) activity by increasing its affinity for the 3'-OH end of the primer-template and stabilizes POLB to those sites where LP-BER proceeds; endonuclease FEN1 cleavage activity on substrates with double, nick, or gap flaps of distinct sequences and lengths; and DNA ligase I (LIG1) on long-patch base excision repair substrates (PubMed:21659603). The 9-1-1 complex is necessary for the recruitment of RHNO1 to sites of double-stranded breaks (DSB) occurring during the S phase (PubMed:21659603). RAD9A possesses 3'->5' double stranded DNA exonuclease activity (PubMed:10713044)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q99638/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/RAD9A","classification":"Common Essential","n_dependent_lines":1053,"n_total_lines":1208,"dependency_fraction":0.8716887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HUS1","stoichiometry":10.0},{"gene":"RAD17","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/search/RAD9A","total_profiled":1310},"omim":[{"mim_id":"614085","title":"RAD9-, RAD1-, AND HUS1-INTERACTING NUCLEAR ORPHAN 1; RHNO1","url":"https://www.omim.org/entry/614085"},{"mim_id":"608368","title":"RAD9 CHECKPOINT CLAMP COMPONENT B; RAD9B","url":"https://www.omim.org/entry/608368"},{"mim_id":"603761","title":"RAD9A CHECKPOINT CLAMP COMPONENT A; RAD9A","url":"https://www.omim.org/entry/603761"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Nuclear bodies","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RAD9A"},"hgnc":{"alias_symbol":[],"prev_symbol":["RAD9"]},"alphafold":{"accession":"Q99638","domains":[{"cath_id":"3.70.10.10","chopping":"1-127","consensus_level":"high","plddt":93.1331,"start":1,"end":127},{"cath_id":"3.70.10.10","chopping":"142-268","consensus_level":"high","plddt":93.9487,"start":142,"end":268}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99638","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99638-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99638-F1-predicted_aligned_error_v6.png","plddt_mean":76.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RAD9A","jax_strain_url":"https://www.jax.org/strain/search?query=RAD9A"},"sequence":{"accession":"Q99638","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99638.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99638/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99638"}},"corpus_meta":[{"pmid":"3291120","id":"PMC_3291120","title":"The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae.","date":"1988","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/3291120","citation_count":1083,"is_preprint":false},{"pmid":"11799063","id":"PMC_11799063","title":"Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11799063","citation_count":422,"is_preprint":false},{"pmid":"17575048","id":"PMC_17575048","title":"The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17575048","citation_count":388,"is_preprint":false},{"pmid":"9657725","id":"PMC_9657725","title":"Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9657725","citation_count":328,"is_preprint":false},{"pmid":"15279787","id":"PMC_15279787","title":"Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex.","date":"2004","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/15279787","citation_count":257,"is_preprint":false},{"pmid":"11511366","id":"PMC_11511366","title":"Budding yeast Rad9 is an ATP-dependent Rad53 activating machine.","date":"2001","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/11511366","citation_count":249,"is_preprint":false},{"pmid":"8514150","id":"PMC_8514150","title":"Cell cycle arrest of cdc mutants and specificity of the RAD9 checkpoint.","date":"1993","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8514150","citation_count":241,"is_preprint":false},{"pmid":"16166626","id":"PMC_16166626","title":"Role of Dot1-dependent histone H3 methylation in G1 and S phase DNA damage checkpoint functions of Rad9.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16166626","citation_count":241,"is_preprint":false},{"pmid":"9755168","id":"PMC_9755168","title":"The budding yeast Rad9 checkpoint protein is subjected to Mec1/Tel1-dependent hyperphosphorylation and interacts with Rad53 after DNA damage.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9755168","citation_count":233,"is_preprint":false},{"pmid":"17636252","id":"PMC_17636252","title":"The Rad9-Hus1-Rad1 checkpoint clamp regulates interaction of TopBP1 with ATR.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17636252","citation_count":232,"is_preprint":false},{"pmid":"10871397","id":"PMC_10871397","title":"Structure-based predictions of Rad1, Rad9, Hus1 and Rad17 participation in sliding clamp and clamp-loading complexes.","date":"2000","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/10871397","citation_count":217,"is_preprint":false},{"pmid":"2247073","id":"PMC_2247073","title":"Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts posttranslationally in cell cycle arrest after DNA damage.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2247073","citation_count":202,"is_preprint":false},{"pmid":"10648611","id":"PMC_10648611","title":"Characterization of Schizosaccharomyces pombe Hus1: a PCNA-related protein that associates with Rad1 and Rad9.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10648611","citation_count":202,"is_preprint":false},{"pmid":"16085488","id":"PMC_16085488","title":"Saccharomyces cerevisiae Rad9 acts as a Mec1 adaptor to allow Rad53 activation.","date":"2005","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16085488","citation_count":195,"is_preprint":false},{"pmid":"12049741","id":"PMC_12049741","title":"Rad9 phosphorylation sites couple Rad53 to the Saccharomyces cerevisiae DNA damage checkpoint.","date":"2002","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12049741","citation_count":194,"is_preprint":false},{"pmid":"8367452","id":"PMC_8367452","title":"RAD9-dependent G1 arrest defines a second checkpoint for damaged DNA in the cell cycle of Saccharomyces cerevisiae.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8367452","citation_count":184,"is_preprint":false},{"pmid":"9017389","id":"PMC_9017389","title":"RAD9, RAD17, and RAD24 are required for S phase regulation in Saccharomyces cerevisiae in response to DNA damage.","date":"1997","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9017389","citation_count":169,"is_preprint":false},{"pmid":"9872989","id":"PMC_9872989","title":"Human homologs of Schizosaccharomyces pombe rad1, hus1, and rad9 form a DNA damage-responsive protein complex.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9872989","citation_count":168,"is_preprint":false},{"pmid":"18418382","id":"PMC_18418382","title":"Histone methyltransferase Dot1 and Rad9 inhibit single-stranded DNA accumulation at DSBs and uncapped telomeres.","date":"2008","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/18418382","citation_count":163,"is_preprint":false},{"pmid":"8895664","id":"PMC_8895664","title":"RAD9 and DNA polymerase epsilon form parallel sensory branches for transducing the DNA damage checkpoint signal in Saccharomyces cerevisiae.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8895664","citation_count":139,"is_preprint":false},{"pmid":"18936170","id":"PMC_18936170","title":"The basic cleft of RPA70N binds multiple checkpoint proteins, including RAD9, to regulate ATR signaling.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18936170","citation_count":137,"is_preprint":false},{"pmid":"12628935","id":"PMC_12628935","title":"Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12628935","citation_count":131,"is_preprint":false},{"pmid":"2664461","id":"PMC_2664461","title":"Cloning and sequence analysis of the Saccharomyces cerevisiae RAD9 gene and further evidence that its product is required for cell cycle arrest induced by DNA damage.","date":"1989","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2664461","citation_count":130,"is_preprint":false},{"pmid":"9564050","id":"PMC_9564050","title":"RAD9 and RAD24 define two additive, interacting branches of the DNA damage checkpoint pathway in budding yeast normally required for Rad53 modification and activation.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9564050","citation_count":128,"is_preprint":false},{"pmid":"17721446","id":"PMC_17721446","title":"Rad9 BRCT domain interaction with phosphorylated H2AX regulates the G1 checkpoint in budding yeast.","date":"2007","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/17721446","citation_count":126,"is_preprint":false},{"pmid":"10620799","id":"PMC_10620799","title":"Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10620799","citation_count":122,"is_preprint":false},{"pmid":"16479004","id":"PMC_16479004","title":"Mammalian Rad9 plays a role in telomere stability, S- and G2-phase-specific cell survival, and homologous recombinational repair.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16479004","citation_count":118,"is_preprint":false},{"pmid":"15282322","id":"PMC_15282322","title":"Deletion of mouse rad9 causes abnormal cellular responses to DNA damage, genomic instability, and embryonic lethality.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15282322","citation_count":107,"is_preprint":false},{"pmid":"21946560","id":"PMC_21946560","title":"Dpb11 coordinates Mec1 kinase activation with cell cycle-regulated Rad9 recruitment.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21946560","citation_count":106,"is_preprint":false},{"pmid":"16650810","id":"PMC_16650810","title":"Histone H2A phosphorylation and H3 methylation are required for a novel Rad9 DSB repair function following checkpoint activation.","date":"2006","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/16650810","citation_count":105,"is_preprint":false},{"pmid":"8670896","id":"PMC_8670896","title":"A novel role for the budding yeast RAD9 checkpoint gene in DNA damage-dependent transcription.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8670896","citation_count":104,"is_preprint":false},{"pmid":"15314187","id":"PMC_15314187","title":"The human Rad9/Rad1/Hus1 damage sensor clamp interacts with DNA polymerase beta and increases its DNA substrate utilisation efficiency: implications for DNA repair.","date":"2004","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15314187","citation_count":103,"is_preprint":false},{"pmid":"19446481","id":"PMC_19446481","title":"Crystal structure of the rad9-rad1-hus1 DNA damage checkpoint complex--implications for clamp loading and regulation.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19446481","citation_count":102,"is_preprint":false},{"pmid":"15190204","id":"PMC_15190204","title":"ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.","date":"2004","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/15190204","citation_count":101,"is_preprint":false},{"pmid":"17243194","id":"PMC_17243194","title":"Docking onto chromatin via the Saccharomyces cerevisiae Rad9 Tudor domain.","date":"2007","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17243194","citation_count":98,"is_preprint":false},{"pmid":"12709442","id":"PMC_12709442","title":"Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12709442","citation_count":98,"is_preprint":false},{"pmid":"25569305","id":"PMC_25569305","title":"Functional interplay between the 53BP1-ortholog Rad9 and the Mre11 complex regulates resection, end-tethering and repair of a double-strand break.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25569305","citation_count":94,"is_preprint":false},{"pmid":"15897895","id":"PMC_15897895","title":"Interaction and colocalization of Rad9/Rad1/Hus1 checkpoint complex with replication protein A in human cells.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15897895","citation_count":93,"is_preprint":false},{"pmid":"15556996","id":"PMC_15556996","title":"The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15556996","citation_count":88,"is_preprint":false},{"pmid":"1852603","id":"PMC_1852603","title":"Cloning and characterisation of the rad9 DNA repair gene from Schizosaccharomyces pombe.","date":"1991","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1852603","citation_count":86,"is_preprint":false},{"pmid":"9535829","id":"PMC_9535829","title":"Hydrogen peroxide causes RAD9-dependent cell cycle arrest in G2 in Saccharomyces cerevisiae whereas menadione causes G1 arrest independent of RAD9 function.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9535829","citation_count":84,"is_preprint":false},{"pmid":"23160493","id":"PMC_23160493","title":"DNA-repair scaffolds dampen checkpoint signalling by counteracting the adaptor Rad9.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23160493","citation_count":83,"is_preprint":false},{"pmid":"16879101","id":"PMC_16879101","title":"Physical and functional interactions between MutY glycosylase homologue (MYH) and checkpoint proteins Rad9-Rad1-Hus1.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16879101","citation_count":82,"is_preprint":false},{"pmid":"11971963","id":"PMC_11971963","title":"c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11971963","citation_count":80,"is_preprint":false},{"pmid":"10339432","id":"PMC_10339432","title":"The BRCT domain of the S. cerevisiae checkpoint protein Rad9 mediates a Rad9-Rad9 interaction after DNA damage.","date":"1999","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10339432","citation_count":78,"is_preprint":false},{"pmid":"12167163","id":"PMC_12167163","title":"Clamp and clamp loader structures of the human checkpoint protein complexes, Rad9-1-1 and Rad17-RFC.","date":"2002","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/12167163","citation_count":77,"is_preprint":false},{"pmid":"19535328","id":"PMC_19535328","title":"Structure and functional implications of the human rad9-hus1-rad1 cell cycle checkpoint complex.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19535328","citation_count":71,"is_preprint":false},{"pmid":"11124038","id":"PMC_11124038","title":"Structure of the FHA1 domain of yeast Rad53 and identification of binding sites for both FHA1 and its target protein Rad9.","date":"2000","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11124038","citation_count":67,"is_preprint":false},{"pmid":"9488434","id":"PMC_9488434","title":"The Saccharomyces cerevisiae RAD9 checkpoint reduces the DNA damage-associated stimulation of directed translocations.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9488434","citation_count":66,"is_preprint":false},{"pmid":"20724438","id":"PMC_20724438","title":"Structure and function of the Rad9-binding region of the DNA-damage checkpoint adaptor TopBP1.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20724438","citation_count":66,"is_preprint":false},{"pmid":"21321020","id":"PMC_21321020","title":"A role for the arginine methylation of Rad9 in checkpoint control and cellular sensitivity to DNA damage.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21321020","citation_count":66,"is_preprint":false},{"pmid":"12228248","id":"PMC_12228248","title":"Genotoxin-induced Rad9-Hus1-Rad1 (9-1-1) chromatin association is an early checkpoint signaling event.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12228248","citation_count":66,"is_preprint":false},{"pmid":"8385050","id":"PMC_8385050","title":"A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest.","date":"1993","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8385050","citation_count":65,"is_preprint":false},{"pmid":"17395641","id":"PMC_17395641","title":"The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates NEIL1 glycosylase.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17395641","citation_count":65,"is_preprint":false},{"pmid":"19464297","id":"PMC_19464297","title":"Crystal structure of the human rad9-hus1-rad1 clamp.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19464297","citation_count":63,"is_preprint":false},{"pmid":"18940270","id":"PMC_18940270","title":"Tousled homolog, TLK1, binds and phosphorylates Rad9; TLK1 acts as a molecular chaperone in DNA repair.","date":"2008","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18940270","citation_count":63,"is_preprint":false},{"pmid":"20700441","id":"PMC_20700441","title":"Dynamics of Rad9 chromatin binding and checkpoint function are mediated by its dimerization and are cell cycle-regulated by CDK1 activity.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20700441","citation_count":61,"is_preprint":false},{"pmid":"17426133","id":"PMC_17426133","title":"The checkpoint clamp, Rad9-Rad1-Hus1 complex, preferentially stimulates the activity of apurinic/apyrimidinic endonuclease 1 and DNA polymerase beta in long patch base excision repair.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17426133","citation_count":61,"is_preprint":false},{"pmid":"16216273","id":"PMC_16216273","title":"The two DNA clamps Rad9/Rad1/Hus1 complex and proliferating cell nuclear antigen differentially regulate flap endonuclease 1 activity.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16216273","citation_count":60,"is_preprint":false},{"pmid":"8846891","id":"PMC_8846891","title":"The rad9 gene of Coprinus cinereus encodes a proline-rich protein required for meiotic chromosome condensation and synapsis.","date":"1996","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8846891","citation_count":59,"is_preprint":false},{"pmid":"16204032","id":"PMC_16204032","title":"The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16204032","citation_count":57,"is_preprint":false},{"pmid":"17855402","id":"PMC_17855402","title":"The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates DNA repair enzyme TDG glycosylase.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17855402","citation_count":55,"is_preprint":false},{"pmid":"25637499","id":"PMC_25637499","title":"Escape of Sgs1 from Rad9 inhibition reduces the requirement for Sae2 and functional MRX in DNA end resection.","date":"2015","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/25637499","citation_count":55,"is_preprint":false},{"pmid":"20816984","id":"PMC_20816984","title":"A structural hinge in eukaryotic MutY homologues mediates catalytic activity and Rad9-Rad1-Hus1 checkpoint complex interactions.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20816984","citation_count":55,"is_preprint":false},{"pmid":"12546694","id":"PMC_12546694","title":"Role of the Saccharomyces cerevisiae Rad9 protein in sensing and responding to DNA damage.","date":"2003","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/12546694","citation_count":54,"is_preprint":false},{"pmid":"2699734","id":"PMC_2699734","title":"Control of G2 delay by the rad9 gene of Saccharomyces cerevisiae.","date":"1989","source":"Journal of cell science. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/2699734","citation_count":54,"is_preprint":false},{"pmid":"16365875","id":"PMC_16365875","title":"Rad9, an evolutionarily conserved gene with multiple functions for preserving genomic integrity.","date":"2006","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16365875","citation_count":53,"is_preprint":false},{"pmid":"14709724","id":"PMC_14709724","title":"A domain of Rad9 specifically required for activation of Chk1 in budding yeast.","date":"2004","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/14709724","citation_count":53,"is_preprint":false},{"pmid":"30158111","id":"PMC_30158111","title":"Mrc1 and Rad9 cooperate to regulate initiation and elongation of DNA replication in response to DNA damage.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/30158111","citation_count":52,"is_preprint":false},{"pmid":"23468651","id":"PMC_23468651","title":"Conditional inactivation of the DNA damage response gene Hus1 in mouse testis reveals separable roles for components of the RAD9-RAD1-HUS1 complex in meiotic chromosome maintenance.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23468651","citation_count":50,"is_preprint":false},{"pmid":"22586102","id":"PMC_22586102","title":"Repair complexes of FEN1 endonuclease, DNA, and Rad9-Hus1-Rad1 are distinguished from their PCNA counterparts by functionally important stability.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22586102","citation_count":48,"is_preprint":false},{"pmid":"1588907","id":"PMC_1588907","title":"Molecular cloning and analysis of Schizosaccharomyces pombe rad9, a gene involved in DNA repair and mutagenesis.","date":"1992","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/1588907","citation_count":47,"is_preprint":false},{"pmid":"19332880","id":"PMC_19332880","title":"The Dot1 histone methyltransferase and the Rad9 checkpoint adaptor contribute to cohesin-dependent double-strand break repair by sister chromatid recombination in Saccharomyces cerevisiae.","date":"2009","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19332880","citation_count":46,"is_preprint":false},{"pmid":"16890531","id":"PMC_16890531","title":"Telomere and telomerase modulation by the mammalian Rad9/Rad1/Hus1 DNA-damage-checkpoint complex.","date":"2006","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16890531","citation_count":44,"is_preprint":false},{"pmid":"15060150","id":"PMC_15060150","title":"Association of Rad9 with double-strand breaks through a Mec1-dependent mechanism.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15060150","citation_count":44,"is_preprint":false},{"pmid":"15184659","id":"PMC_15184659","title":"Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15184659","citation_count":44,"is_preprint":false},{"pmid":"30510002","id":"PMC_30510002","title":"Sae2 antagonizes Rad9 accumulation at DNA double-strand breaks to attenuate checkpoint signaling and facilitate end resection.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30510002","citation_count":42,"is_preprint":false},{"pmid":"18316588","id":"PMC_18316588","title":"Rad9 has a functional role in human prostate carcinogenesis.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18316588","citation_count":42,"is_preprint":false},{"pmid":"26063178","id":"PMC_26063178","title":"SIRT6 protein deacetylase interacts with MYH DNA glycosylase, APE1 endonuclease, and Rad9-Rad1-Hus1 checkpoint clamp.","date":"2015","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26063178","citation_count":41,"is_preprint":false},{"pmid":"18842633","id":"PMC_18842633","title":"Rad9 plays an important role in DNA mismatch repair through physical interaction with MLH1.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18842633","citation_count":40,"is_preprint":false},{"pmid":"11739777","id":"PMC_11739777","title":"Structure-function analysis of fission yeast Hus1-Rad1-Rad9 checkpoint complex.","date":"2001","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/11739777","citation_count":40,"is_preprint":false},{"pmid":"10996309","id":"PMC_10996309","title":"Schizosaccharomyces pombe Rad9 contains a BH3-like region and interacts with the anti-apoptotic protein Bcl-2.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10996309","citation_count":40,"is_preprint":false},{"pmid":"20021694","id":"PMC_20021694","title":"TLK1B promotes repair of DSBs via its interaction with Rad9 and Asf1.","date":"2009","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20021694","citation_count":39,"is_preprint":false},{"pmid":"21278450","id":"PMC_21278450","title":"The role of RAD9 in tumorigenesis.","date":"2011","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21278450","citation_count":38,"is_preprint":false},{"pmid":"20545769","id":"PMC_20545769","title":"Casein kinase 2-dependent phosphorylation of human Rad9 mediates the interaction between human Rad9-Hus1-Rad1 complex and TopBP1.","date":"2010","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/20545769","citation_count":38,"is_preprint":false},{"pmid":"15066121","id":"PMC_15066121","title":"Critical role for chicken Rad17 and Rad9 in the cellular response to DNA damage and stalled DNA replication.","date":"2004","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/15066121","citation_count":38,"is_preprint":false},{"pmid":"20808892","id":"PMC_20808892","title":"Survival and growth of yeast without telomere capping by Cdc13 in the absence of Sgs1, Exo1, and Rad9.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20808892","citation_count":37,"is_preprint":false},{"pmid":"23066031","id":"PMC_23066031","title":"Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23066031","citation_count":35,"is_preprint":false},{"pmid":"14988409","id":"PMC_14988409","title":"Rad9 protects cells from topoisomerase poison-induced cell death.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14988409","citation_count":35,"is_preprint":false},{"pmid":"28140789","id":"PMC_28140789","title":"p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks.","date":"2017","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/28140789","citation_count":34,"is_preprint":false},{"pmid":"32780107","id":"PMC_32780107","title":"DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation.","date":"2021","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/32780107","citation_count":34,"is_preprint":false},{"pmid":"25091155","id":"PMC_25091155","title":"Interaction between Rad9-Hus1-Rad1 and TopBP1 activates ATR-ATRIP and promotes TopBP1 recruitment to sites of UV-damage.","date":"2014","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/25091155","citation_count":33,"is_preprint":false},{"pmid":"21095590","id":"PMC_21095590","title":"DDK phosphorylates checkpoint clamp component Rad9 and promotes its release from damaged chromatin.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21095590","citation_count":33,"is_preprint":false},{"pmid":"19020305","id":"PMC_19020305","title":"ATR and Rad17 collaborate in modulating Rad9 localisation at sites of DNA damage.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/19020305","citation_count":32,"is_preprint":false},{"pmid":"12455955","id":"PMC_12455955","title":"Involvement of RAD9-dependent damage checkpoint control in arrest of cell cycle, induction of cell death, and chromosome instability caused by defects in origin recognition complex in Saccharomyces cerevisiae.","date":"2002","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/12455955","citation_count":32,"is_preprint":false},{"pmid":"18215141","id":"PMC_18215141","title":"Identification of androgen-selective androgen-response elements in the human aquaporin-5 and Rad9 genes.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18215141","citation_count":31,"is_preprint":false},{"pmid":"22034047","id":"PMC_22034047","title":"Contributions of Rad9 to tumorigenesis.","date":"2012","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22034047","citation_count":30,"is_preprint":false},{"pmid":"24376897","id":"PMC_24376897","title":"Tousled-like kinase-dependent phosphorylation of Rad9 plays a role in cell cycle progression and G2/M checkpoint exit.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24376897","citation_count":30,"is_preprint":false},{"pmid":"14508514","id":"PMC_14508514","title":"Caspase-3-mediated cleavage of Rad9 during apoptosis.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14508514","citation_count":30,"is_preprint":false},{"pmid":"16436514","id":"PMC_16436514","title":"Phosphorylation of Xenopus Rad1 and Hus1 defines a readout for ATR activation that is independent of Claspin and the Rad9 carboxy terminus.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16436514","citation_count":30,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45401,"output_tokens":13918,"usd":0.172486,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":26048,"output_tokens":7524,"usd":0.15917,"stage2_stop_reason":"end_turn"},"total_usd":0.331656,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"RAD9 gene product is essential for G2 cell cycle arrest in response to DNA damage in S. cerevisiae; rad9 mutant cells fail to delay division after irradiation and die, whereas wild-type cells arrest in G2 until damage is repaired.\",\n      \"method\": \"Genetic analysis of rad9 mutants, X-ray irradiation, cell cycle analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — foundational genetic epistasis with clean loss-of-function phenotype, replicated across multiple conditions and cell cycle phases, independently confirmed by multiple subsequent studies\",\n      \"pmids\": [\"3291120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"RAD9-dependent G2 arrest and recovery from arrest can occur in the presence of cycloheximide, demonstrating the mechanism is posttranslational; rad9 null mutants are viable but show elevated spontaneous chromosome loss.\",\n      \"method\": \"Cycloheximide treatment, deletion mutant construction, chromosome loss assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct pharmacological and genetic experiments establishing posttranslational mechanism, replicated across conditions\",\n      \"pmids\": [\"2247073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"RAD9 checkpoint is phase-specific (late S/G2) and signal-specific (DNA lesions), and RAD17 is also required for the same checkpoint; both genes are required for G2 arrest after X- or UV-irradiation.\",\n      \"method\": \"Genetic epistasis with cdc mutants, cell cycle analysis, double-mutant analysis\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis across multiple cdc mutants and radiation conditions, replicated\",\n      \"pmids\": [\"8514150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"RAD9 is required for DNA damage-induced G1 arrest (G1/S checkpoint) in S. cerevisiae, in addition to its known G2 checkpoint role.\",\n      \"method\": \"Alpha-factor G1 synchronization, UV/gamma-irradiation, cell cycle analysis in rad9 mutants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean loss-of-function with specific cell cycle phenotype, replicated by other labs\",\n      \"pmids\": [\"8367452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"RAD9 is required for DNA damage-dependent transcriptional induction of a large regulon of repair, replication, and recombination genes; this transcriptional response is cell cycle-independent.\",\n      \"method\": \"Northern blot analysis, lacZ reporter assays, RAD9 deletion mutants\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (Northern blot, reporter assays) in single lab demonstrating RAD9-dependent transcriptional regulation\",\n      \"pmids\": [\"8670896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"RAD9 and DNA polymerase epsilon (POL2) function in parallel sensory branches upstream of Rad53 for transducing the UV DNA damage checkpoint signal; both branches independently activate Mec1/Rad53.\",\n      \"method\": \"Genetic epistasis, Rad53 phosphorylation assays, RNR3 induction assays in double mutants\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with biochemical readout (Rad53 phosphorylation) across multiple mutant combinations\",\n      \"pmids\": [\"8895664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RAD9, RAD17, and RAD24 are required for S-phase regulation (slowing of S-phase progression) in response to alkylation damage in S. cerevisiae, acting upstream of MEC1 and RAD53.\",\n      \"method\": \"S-phase progression assays, epistasis analysis with mec1 and rad53 mutants\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis with clear S-phase readout but single lab\",\n      \"pmids\": [\"9017389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Rad9 is hyperphosphorylated in response to DNA damage in a MEC1- and TEL1-dependent manner in S. cerevisiae; hyperphosphorylated Rad9 physically associates with Rad53 after damage.\",\n      \"method\": \"Phosphatase treatment, Western blot, co-immunoprecipitation, checkpoint gene epistasis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP with biochemical validation of phosphorylation dependency, replicated by multiple labs\",\n      \"pmids\": [\"9755168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The C-terminal FHA domain of Rad53 specifically recognizes phosphorylated Rad9; this interaction is required for DNA damage-dependent Rad53 phosphorylation and G2/M checkpoint arrest in S. cerevisiae.\",\n      \"method\": \"FHA domain mutagenesis, co-immunoprecipitation, checkpoint functional assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — FHA domain mutagenesis with functional readouts (checkpoint arrest, Rad53 phosphorylation), replicated and extended by multiple labs\",\n      \"pmids\": [\"9657725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RAD9 and RAD24 define two additive, interacting branches of the DNA damage checkpoint pathway upstream of MEC1 and RAD53; the double rad9Δ-rad24Δ mutant abolishes the G1/S checkpoint and essentially eliminates transcriptional damage response.\",\n      \"method\": \"Double-mutant epistasis, checkpoint delay assays, transcriptional induction assays, Rad53 modification analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (genetic, biochemical) establishing pathway position\",\n      \"pmids\": [\"9564050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human Rad9, Rad1, and Hus1 form a DNA damage-responsive heterotrimeric protein complex; hRad9 is phosphorylated in response to DNA damage.\",\n      \"method\": \"Co-immunoprecipitation of human proteins, DNA damage treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP demonstrating complex formation, replicated by other labs\",\n      \"pmids\": [\"9872989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The BRCT domain of yeast Rad9 mediates Rad9-Rad9 homo-oligomerization, preferentially interacting with hyperphosphorylated Rad9; BRCT mutations abolish Rad9 hyperphosphorylation, Rad53 phosphorylation, and checkpoint function.\",\n      \"method\": \"Two-hybrid, in vitro and in vivo co-immunoprecipitation, BRCT point mutagenesis, checkpoint survival assays\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — mutagenesis combined with biochemical and functional validation in single lab using multiple methods\",\n      \"pmids\": [\"10339432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Structure predictions indicate Rad9, Rad1, and Hus1 each share a PCNA-like fold and form a heterotrimeric ring analogous to the PCNA sliding clamp; Rad17 has RFC-like ATPase clamp-loader properties.\",\n      \"method\": \"Computational fold recognition, comparative modeling, generalized sequence profiles\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction only, no experimental validation in this paper\",\n      \"pmids\": [\"10871397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"S. pombe Hus1 forms a stable complex with Rad9 and Rad1 in vivo; Hus1 nuclear localization depends on Rad17.\",\n      \"method\": \"Co-immunoprecipitation, fractionation, indirect immunofluorescence\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (co-IP, localization) in single lab\",\n      \"pmids\": [\"10648611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Human RAD9 interacts with the anti-apoptotic proteins BCL-2 and BCL-xL (but not pro-apoptotic BAX/BAD) and overexpression induces apoptosis that can be blocked by BCL-2 or BCL-xL; antisense RAD9 suppresses DNA damage-induced cell death.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, overexpression in mammalian cells, antisense knockdown\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus functional gain/loss-of-function experiments, replicated\",\n      \"pmids\": [\"10620799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Solution structure of Rad53 FHA1 domain determined; a phospho-Thr peptide from Rad9 (pThr-192, motif pTXXD) binds FHA1 with Kd ~0.36 μM, identifying the molecular basis for Rad9-Rad53 interaction.\",\n      \"method\": \"NMR structure determination, peptide library screening, surface plasmon resonance\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with binding quantification, identifies specific phosphorylation site\",\n      \"pmids\": [\"11124038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Yeast Rad9 forms two distinct large complexes: a >850 kDa complex with hypophosphorylated Rad9 in undamaged cells, and a 560 kDa complex with hyperphosphorylated Rad9 and Rad53 after damage. The 560 kDa complex catalyzes Rad53 activation via Rad53 in trans autophosphorylation (scaffold mechanism); this requires Rad53 kinase activity but not Mec1/Tel1 once the complex forms.\",\n      \"method\": \"Gel filtration, co-immunoprecipitation, in vitro kinase reconstitution assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution of Rad53 activation by purified Rad9 complex with multiple orthogonal methods\",\n      \"pmids\": [\"11511366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In S. pombe, the Hus1-Rad1-Rad9 complex has PCNA-like structural and functional features; mutations designed using the PCNA alignment identify functionally important residues, though the complex also has unique features distinct from PCNA.\",\n      \"method\": \"Structure-function mutagenesis, checkpoint assays in fission yeast\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis-based functional validation, single lab\",\n      \"pmids\": [\"11739777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Human Rad17 recruits the Rad9 complex (9-1-1) onto chromatin after DNA damage; Rad17 binds chromatin prior to damage and is phosphorylated by ATR on chromatin after damage; Rad17 phosphorylation is not required for Rad9 loading; Hus1 is required for damage-induced Rad17 phosphorylation.\",\n      \"method\": \"Chromatin fractionation, co-immunoprecipitation, kinase inhibition, siRNA knockdown\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — chromatin fractionation with multiple genetic/biochemical controls, replicated by multiple labs\",\n      \"pmids\": [\"11799063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Multiple Mec1/Tel1 consensus [S/T]Q sites within yeast Rad9 are phosphorylated in response to DNA damage; these Rad9 phosphorylation sites are selectively required for Rad53 (not Chk1) branch activation; phospho-Rad9 peptides bind Rad53 FHA domains in vitro.\",\n      \"method\": \"Site-directed mutagenesis of SQ sites, in vitro FHA domain pulldown with phosphopeptides, checkpoint functional assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with in vitro binding and in vivo functional assays\",\n      \"pmids\": [\"12049741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Electron microscopy of reconstituted human 9-1-1 complex reveals a ring structure indistinguishable in shape and size from PCNA; Rad17-RFC forms an oval clamp-loader complex with ATPase activity and binds Rad9-1-1.\",\n      \"method\": \"Baculovirus reconstitution, electron microscopy, native molecular mass determination, ATPase assay\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct structural visualization by EM of reconstituted complex with biochemical characterization\",\n      \"pmids\": [\"12167163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"c-Abl tyrosine kinase constitutively binds Rad9 via its SH3 domain interacting with the Rad9 C-terminal region; c-Abl phosphorylates Rad9 at Tyr-28 (BH3 domain) in vitro and in cells exposed to DNA damage, inducing Rad9 binding to Bcl-xL and contributing to apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis (Tyr-28), apoptosis assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and functional co-IP, single lab\",\n      \"pmids\": [\"11971963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Genotoxin-induced 9-1-1 chromatin binding does not require Rad9 Ser-272 phosphorylation, DNA replication, or ATM/ATR/DNA-PK catalytic activity, indicating chromatin binding is a proximal, kinase-independent event in checkpoint signaling.\",\n      \"method\": \"Chromatin fractionation, PIKK inhibitors, phosphorylation site mutants, replication inhibitors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological and genetic controls, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12228248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Protein kinase Cδ (PKCδ) associates with human Rad9 and phosphorylates it in vitro and in cells after genotoxic stress; PKCδ activation is required for formation of the Rad9-Hus1-Rad1 complex and for Rad9 binding to Bcl-2; inhibition of PKCδ attenuates Rad9-mediated apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, PKCδ inhibitor, checkpoint/apoptosis assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus co-IP and functional consequences, single lab\",\n      \"pmids\": [\"12628935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Phosphorylation of Rad9 C-terminal tail residues (beyond Ser-272) is essential for Chk1 activation following HU, IR, and UV treatment; the Rad9 phospho-tail drives S-phase checkpoint arrest; cells with phosphorylation-deficient Rad9 are as UV/HU sensitive as Rad9-null cells.\",\n      \"method\": \"Site-directed mutagenesis of nine phosphorylation sites, complementation of Mrad9-/- ES cells, checkpoint assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis with functional complementation in null cells across multiple damage types\",\n      \"pmids\": [\"12709442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Human RAD9 can directly bind a p53 consensus DNA-binding sequence in the p21 promoter and transactivate p21 transcription; RAD9 overexpression increases p21 RNA and protein levels.\",\n      \"method\": \"Luciferase reporter assay, EMSA, overexpression, Northern blot, microarray\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus reporter assays demonstrating direct DNA binding and transactivation, single lab\",\n      \"pmids\": [\"15184659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The 9-1-1 complex physically interacts with DNA polymerase beta in vitro and stimulates its activity, increasing affinity for primer-template and stimulating displacement synthesis; this effect is specific to Pol beta and not Pol lambda, Pol alpha, or Pol delta.\",\n      \"method\": \"In vitro pulldown, DNA polymerase activity assays, gel shift assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution with specificity controls across multiple polymerases\",\n      \"pmids\": [\"15314187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The 9-1-1 complex binds and stimulates Flap Endonuclease 1 (FEN1) on flap, nick, and gapped substrates; stimulation is distinct from PCNA stimulation and cannot substitute for PCNA in stimulating Pol beta.\",\n      \"method\": \"In vitro binding assay, FEN1 nuclease activity assays on multiple substrates\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with multiple substrates and mechanistic dissection, replicated by other labs\",\n      \"pmids\": [\"15556996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mammalian Rad9 deletion sensitizes cells to camptothecin, etoposide, and cytarabine; Rad9 is required for cytarabine-induced S-phase checkpoint but not for camptothecin/etoposide S-phase checkpoint; Rad9's predominant role in ES cells is promoting survival after replication stress.\",\n      \"method\": \"Rad9-/- ES cells, clonogenic survival, S-phase checkpoint assays ([3H]thymidine incorporation, Cdc25A), apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with multiple readouts, single lab\",\n      \"pmids\": [\"14988409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"A specific N-terminal domain of yeast Rad9 (Chk1 activation domain, CAD) is required for Chk1 phosphorylation/activation but not for Rad53 activation, demonstrating that Rad9 activates Rad53 and Chk1 through separable domains.\",\n      \"method\": \"Rad9 domain deletion analysis, Chk1 and Rad53 phosphorylation assays, checkpoint functional assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mutagenesis with specific kinase readouts, single lab\",\n      \"pmids\": [\"14709724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mec1 phosphorylates Rad9 at S/TQ motifs in vitro and promotes Rad9 accumulation at double-strand breaks (DSBs) in vivo; multiple SQ motif mutations reduce Rad9 association with DSBs; Rad9 association with DSBs is required for full Rad9 phosphorylation and Rad9-Rad53 interaction.\",\n      \"method\": \"ChIP assay, in vitro kinase assay (Mec1), mec1 mutants, SQ motif mutagenesis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with in vivo ChIP validation and mutagenesis, single lab\",\n      \"pmids\": [\"15060150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mouse Rad9 (Mrad9) deletion causes embryonic lethality at midgestation; Mrad9-/- cells show increased chromosome aberrations, HPRT mutations, and extreme sensitivity to UV, gamma rays, and hydroxyurea; ectopic expression of Mrad9 or human HRAD9 complements these defects.\",\n      \"method\": \"Targeted gene deletion, embryonic stem cell analysis, clonogenic survival, mutation frequency, complementation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with multiple phenotypic readouts and complementation, independent of checkpoint analysis\",\n      \"pmids\": [\"15282322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Dot1-dependent methylation of histone H3 Lys79 is required for Rad9 binding to DSBs and for Rad53 phosphorylation in G1 and S-phase checkpoints; mutation of the Rad9 Tudor domain (responsible for binding methylated H3K79) phenocopies the dot1Δ checkpoint defect.\",\n      \"method\": \"Checkpoint assays in dot1Δ/H3K79 mutants, Rad9 Tudor domain mutagenesis, Rad53 phosphorylation, DSB binding assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with mechanistic link to histone modification and Rad9 Tudor domain mutagenesis\",\n      \"pmids\": [\"16166626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Yeast Rad9 acts as a bona fide signaling adaptor (not scaffold) that enables efficient, direct phosphorylation of Rad53 by Mec1 through a phospho- and FHA-dependent Rad9-Rad53 interaction; Rad9 stimulates Mec1 to phosphorylate Rad53 in biochemical reconstitution.\",\n      \"method\": \"Biochemical reconstitution with purified Rad9, Rad53 phosphorylation mapping by mass spectrometry, in vitro kinase assays\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution with purified components, mass spectrometry-based phosphosite mapping\",\n      \"pmids\": [\"16085488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RAD9-Hus1-Rad1 (9-1-1) interacts with RPA in human cells; Rad9 binds both RPA70 and RPA32 subunits; UV/camptothecin stimulate 9-1-1/RPA interaction; RPA siRNA knockdown blocks damage-dependent chromatin association of 9-1-1 and 9-1-1 complex formation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, nuclear focus colocalization, chromatin fractionation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (co-IP, siRNA, chromatin fractionation) in single lab\",\n      \"pmids\": [\"15897895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mammalian Rad9 interacts with Rad51; Mrad9 inactivation leads to increased telomere end-to-end associations, telomere loss, delayed gamma-H2AX focus kinetics, and reduced homologous recombination repair, indicating a role in HR and telomere stability.\",\n      \"method\": \"Co-immunoprecipitation, HR repair assays, telomere FISH, gamma-H2AX focus analysis, Rad9 conditional knockdown\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus multiple functional assays, single lab\",\n      \"pmids\": [\"16479004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The 9-1-1 complex (via Rad9 and Hus1 individually and as complex) interacts with and stimulates NEIL1 DNA glycosylase activity; Rad9 and NEIL1 colocalize to nuclear foci in H2O2-treated cells.\",\n      \"method\": \"Co-immunoprecipitation, in vitro glycosylase stimulation assay, immunofluorescence co-localization\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro biochemical stimulation plus in vivo co-IP and co-localization, single lab\",\n      \"pmids\": [\"17395641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The mammalian 9-1-1 complex localizes to telomeres and associates with catalytically competent telomerase; Hus1-deficient cells show severe telomere shortening; 9-1-1 positively regulates telomerase DNA polymerase activity.\",\n      \"method\": \"Telomere length measurement (Q-FISH), telomerase activity assay, co-immunoprecipitation with telomerase\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (FISH, telomerase assay, co-IP) in single lab demonstrating telomeric role\",\n      \"pmids\": [\"16890531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rad9's role in Chk1 activation is to recruit TopBP1 to the replication fork; the 9-1-1 clamp's primary function is to localize the ATR-activating domain (AD) of TopBP1 via direct Rad9-TopBP1 binding; fusion of AD to PCNA or H2B bypasses the 9-1-1 requirement.\",\n      \"method\": \"Co-immunoprecipitation, domain fusion experiments, Chk1 phosphorylation assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic bypass experiment (AD fusion to PCNA/H2B) plus co-IP defines functional mechanism, replicated\",\n      \"pmids\": [\"17575048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In Xenopus egg extracts, the C-terminal domain of Rad9 interacts with BRCT I-II of TopBP1 via phosphorylation of Ser-373; this interaction is required for ATR-ATRIP binding to TopBP1's activating domain and for checkpoint signaling; Rad9 Ser-373-Ala and TopBP1 ΔBRCT I-II mutants are checkpoint defective.\",\n      \"method\": \"Xenopus egg extract biochemistry, co-immunoprecipitation, phospho-mutant analysis, Rad9 C-terminal fragment inhibitor\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in egg extracts with phosphosite mutagenesis, domain deletion, and functional inhibitor\",\n      \"pmids\": [\"17636252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rad9 BRCT domain directly interacts with phosphorylated histone H2A in vitro; a Rad9 point mutation abolishing this interaction causes G1 checkpoint defects similar to H2A phosphorylation site mutation; the Tudor domain mediates constitutive chromatin association while BRCT domain-pH2A interaction enables damage-specific G1 arrest.\",\n      \"method\": \"In vitro BRCT-phospho-H2A binding assay, point mutagenesis, G1 checkpoint assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro direct binding with mutagenesis and matching in vivo phenotype\",\n      \"pmids\": [\"17721446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The Rad9 Tudor domain binds to histone H3 methylated at Lys79 (H3K79me) in vitro and is required for Rad9 focal accumulation after DNA damage; Tudor-H3K79me interaction functions in G1 checkpoint activation and G2 DSB repair.\",\n      \"method\": \"In vitro Tudor domain-H3K79me binding assay, Rad9 Tudor mutants, checkpoint assays, focus formation\",\n      \"journal\": \"Yeast (Chichester, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro histone modification binding plus in vivo mutant phenotypes, consistent with other labs' findings\",\n      \"pmids\": [\"17243194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The 9-1-1 complex interacts with and stimulates human TDG glycosylase; Rad9-TDG interaction is enhanced after MNNG treatment; Hus1 binding domain mapped to TDG residues 67-110.\",\n      \"method\": \"Co-immunoprecipitation, glycosylase activity assay, domain mapping mutagenesis, co-localization\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical stimulation assay plus co-IP and domain mapping, single lab\",\n      \"pmids\": [\"17855402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The 9-1-1 complex interacts with APE1 in vitro and in vivo and stimulates APE1 AP-endonuclease activity; the 9-1-1 complex enhances long-patch base excision repair (LP-BER) reconstituted in vitro by specifically stimulating APE1 and Pol beta.\",\n      \"method\": \"In vitro co-immunoprecipitation, APE1 endonuclease assay, LP-BER reconstitution assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution of LP-BER with mechanistic hierarchy established\",\n      \"pmids\": [\"17426133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Dot1 histone methyltransferase and Rad9 (via Tudor domain binding to H3K79me) inhibit DNA end resection at DSBs and uncapped telomeres; loss of Rad9 or Dot1 leads to faster ssDNA accumulation at DSBs via a Rad50-dependent nuclease, accelerating Mec1 activation.\",\n      \"method\": \"ssDNA quantification (QAOS), genetic analysis of dot1Δ and rad9 mutants, DSB resection kinetics\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative ssDNA assay with genetic dissection and multiple controls\",\n      \"pmids\": [\"18418382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The basic cleft of RPA70 N-terminal OB-fold domain binds RAD9 via an acidic peptide in the RAD9 C-terminal tail (checkpoint recruitment domain, CRD); mutation of the RAD9 CRD impairs its localization to damage sites without affecting 9-1-1 complex formation or TopBP1 binding; RAD9-RPA interaction is required for ATR signaling to CHK1.\",\n      \"method\": \"Domain mutagenesis, co-immunoprecipitation, nuclear focus formation assays, Chk1 phosphorylation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mutagenesis with multiple specific functional readouts, single lab\",\n      \"pmids\": [\"18936170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TLK1B phosphorylates human Rad9 at S328; TLK1B overexpression hastens DSB repair and modulates the amount of 9-1-1 at DSBs; Rad9 competes with chromatin assembly factor Asf1 for TLK1B binding.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, ChIP at HO-induced DSB, complementation in Rad9-null cells\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus in vivo ChIP and functional complementation, single lab\",\n      \"pmids\": [\"18940270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Rad9 plays a role in DNA mismatch repair through direct physical interaction with MLH1; a single-point mutation in Rad9 disrupting MLH1 interaction significantly reduces MMR activity without affecting checkpoint functions.\",\n      \"method\": \"Co-immunoprecipitation, MMR activity assay, single-point mutagenesis, checkpoint assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific mutagenesis dissecting MMR from checkpoint function, single lab\",\n      \"pmids\": [\"18842633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of human 9-1-1 complex determined at 3.2 Å (Doré et al.) and at 2.5 Å (Sohn and Cho); the complex forms a toroidal heterotrimeric ring similar to PCNA with a single repair enzyme-binding site on 9-1-1 that can be competitively blocked by p21(cip1/waf1); FEN1 PIP box binds to the IDC loop of Rad1.\",\n      \"method\": \"X-ray crystallography, biochemical competition assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures from two independent labs, biochemical validation of binding sites\",\n      \"pmids\": [\"19446481\", \"19464297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TLK1B promotes repair of DSB ends with incompatible termini through its interaction with Rad9; Rad9 is important for processing ends prior to ligation; TLK1B's kinase activity is required for timely release of Rad17 and Rad9 from the DSB after repair.\",\n      \"method\": \"In vitro plasmid ligation assay, Rad9 immunodepletion, HO-cleavage system, ChIP\",\n      \"journal\": \"BMC molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical end-joining assay with depletion and ChIP, single lab\",\n      \"pmids\": [\"20021694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structure of the N-terminal region of human TopBP1 reveals a triple-BRCT domain; pSer387 of Rad9 (phosphorylated by CK2) specifically interacts with the second (but not third) BRCT domain of TopBP1.\",\n      \"method\": \"X-ray crystallography, phosphopeptide binding assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with defined phosphopeptide binding specificity\",\n      \"pmids\": [\"20724438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Casein kinase 2 (CK2) phosphorylates Rad9 at Ser-341 and Ser-387 in the C-terminal tail; phosphorylation at both sites is required for efficient interaction with TopBP1 in vitro; CK2 phosphorylation is required in vivo and cells expressing phospho-deficient Rad9 are hypersensitive to UV and MMS.\",\n      \"method\": \"In vitro kinase assay with CK2, site-directed mutagenesis, co-immunoprecipitation, clonogenic survival\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and functional in vivo validation\",\n      \"pmids\": [\"20545769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In fission yeast, DDK (Hsk1/Cdc7) phosphorylates Rad9 in response to replication-induced DNA damage; Rad9 phosphorylation by DDK is dependent on prior Rad3(ATR) phosphorylation and disrupts Rad9-RPA interaction, promoting release of Rad9 from DNA damage sites to facilitate repair.\",\n      \"method\": \"Kinase assays, phosphorylation-deficient mutants, DNA repair foci assays, co-immunoprecipitation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — kinase-substrate relationship established in vitro and in vivo with mechanistic consequence demonstrated\",\n      \"pmids\": [\"21095590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In S. cerevisiae, CDK1-dependent phosphorylation of Rad9 on Ser11 creates a binding site for Dpb11, enabling a chromatin-binding-independent pathway for Rad53 activation; BRCT domain-mediated Rad9 dimerization is required for chromatin binding and checkpoint function in G1 and M phases.\",\n      \"method\": \"CDK1 phosphorylation site mutagenesis, Dpb11 interaction assays, BRCT domain mutants, artificial dimerization with GST/FKBP fusions, checkpoint assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mutagenesis approaches with specific pathway dissection, single lab\",\n      \"pmids\": [\"20700441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dpb11 forms a ternary complex with Mec1 and Rad9, required for efficient Rad9 phosphorylation by Mec1 in vitro and checkpoint activation in vivo; CDK1 phosphorylates Rad9 on two key residues, generating a Dpb11 BRCT-binding site for Rad9 recruitment into the ternary complex; this ensures checkpoint signaling is restricted to non-G1 phases.\",\n      \"method\": \"In vitro kinase assay with reconstituted ternary complex, CDK1 phosphosite mutagenesis, Dpb11 interaction assays, checkpoint assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of ternary complex with in vivo checkpoint validation and cell cycle control mechanism\",\n      \"pmids\": [\"21946560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Human Rad9 is methylated by PRMT5 (protein arginine methyltransferase 5); arginine methylation of Rad9 is required for S/M and G2/M checkpoint activation and Chk1 activation; methylation-deficient Rad9 increases cellular sensitivity to DNA damage.\",\n      \"method\": \"Co-immunoprecipitation, in vitro methylation assay, arginine methylation site mutagenesis, Chk1 phosphorylation assays, checkpoint and survival assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro methylation assay plus functional mutagenesis, single lab\",\n      \"pmids\": [\"21321020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DNA-repair scaffolds Slx4 and Rtt107 prevent hyperactivation of checkpoint signaling by competing with the Rad9 adaptor; Slx4-Rtt107 complex physically interacts with Dpb11 and phospho-H2A, thereby reducing Rad9-dependent Rad53 activation; loss of Slx4 or Rtt107 causes Rad53 hyperactivation.\",\n      \"method\": \"Co-immunoprecipitation, epistasis with rad53/H2A hypomorphs, Rad53 phosphorylation assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic competition model with co-IP and genetic rescue, published in high-profile journal\",\n      \"pmids\": [\"23160493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Stable reduction of Rad9 in prostate cancer cells impairs migration, invasion, and anchorage-independent growth; Rad9 promotes anoikis resistance by maintaining integrin β1 expression and Akt activation; Mrad9 expression in Rad9-knockdown cells restores these phenotypes.\",\n      \"method\": \"siRNA and stable shRNA knockdown, migration/invasion assays, anchorage-independent growth, anoikis assays, Akt activation measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — stable knockdown and rescue with multiple functional readouts, single lab\",\n      \"pmids\": [\"23066031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TLK1 phosphorylates Rad9 at Thr355 in vitro and in vivo; this phosphorylation is reduced upon ionizing radiation exposure; TLK1 depletion causes prolonged G2/M arrest after IR, phenocopied by Rad9-T355A overexpression; TLK1 and Chk1 act together to modulate Rad9 phosphorylation status.\",\n      \"method\": \"In vitro kinase assay, phospho-specific analysis, siRNA depletion, T355A mutant overexpression, cell cycle analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with in vivo phosphosite validation and functional mutant phenotype, single lab\",\n      \"pmids\": [\"24376897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The 9-1-1/TopBP1 interaction and ATR activation create a positive feedback loop: 9-1-1 and TopBP1 independently recruit to UV-damage sites, then direct interaction of phospho-Rad9 with TopBP1 activates ATR, which in turn promotes further TopBP1 accumulation at damage sites.\",\n      \"method\": \"Laser UV-microirradiation, live-cell focus analysis, TopBP1-binding-deficient Rad9 mutant, ATR kinase inhibitor\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutant and pharmacological dissection of sequential events in cells, single lab\",\n      \"pmids\": [\"25091155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Yeast Rad9 limits the action of Sgs1/Dna2 at DSBs by inhibiting Sgs1 binding at DSB ends; deletion of RAD9 reduces Mre11 binding to DSBs and restores DSB end-tethering and efficient repair in cells lacking Sae2 or with nuclease-deficient MRX.\",\n      \"method\": \"ChIP at HO-induced DSB, genetic epistasis with sgs1-ss mutant, DSB repair assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with genetic epistasis in multiple mutant combinations, single lab\",\n      \"pmids\": [\"25637499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Rad9 (yeast 53BP1 ortholog) promotes Mre11 retention at persistent DSBs; deletion of RAD9 reduces Mre11 binding, facilitates Rad52 recruitment, and restores end-tethering and repair via an Sgs1-dependent mechanism in sae2Δ cells.\",\n      \"method\": \"ChIP, genetic epistasis, DSB repair and end-tethering assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and genetic analysis in multiple mutant backgrounds, single lab\",\n      \"pmids\": [\"25569305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Sae2 counteracts Rad9 accumulation at DSBs by competing for Tel1 phosphorylation substrates, thereby reducing Rad9 binding to chromatin and to Rad53; this function is independent of Mre11 nuclease activity.\",\n      \"method\": \"ChIP at DSBs, epistasis analysis, Rad53 phosphorylation assays, Tel1 substrate competition analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and biochemical analysis with genetic dissection, single lab\",\n      \"pmids\": [\"30510002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Mrc1 and Rad9 control DNA replication through complementary mechanisms: Mrc1 rapidly activates Rad53 at stalled forks to repress late-firing origins, while Rad9 takes over to maintain sustained checkpoint signaling; Rad9-mediated Rad53 activation slows fork progression.\",\n      \"method\": \"DNA combing, origin firing analysis, Rad53 phosphorylation kinetics, genetic epistasis between mrc1 and rad9 mutants\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — DNA combing with genetic analysis in single lab demonstrating distinct mechanisms\",\n      \"pmids\": [\"30158111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Caspase-3 cleaves human Rad9 at multiple sites; cleavage results in translocation of the N-terminal BH3-containing fragment from nucleus to cytosol, where it binds Bcl-XL and promotes apoptosis; cleavage-resistant Rad9 DDD/AAA mutant protects cells from DNA damage-induced apoptosis.\",\n      \"method\": \"In vitro caspase-3 cleavage assay, site-directed mutagenesis, caspase inhibitors, caspase-3-deficient MCF-7 cells, immunofluorescence, apoptosis assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro cleavage reconstitution with mutagenesis and cell-based validation, mechanistic consequence demonstrated\",\n      \"pmids\": [\"14508514\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RAD9A (human RAD9) encodes the RAD9 subunit of the heterotrimeric 9-1-1 (RAD9-HUS1-RAD1) PCNA-like sliding clamp, which is loaded onto RPA-coated ssDNA at damage sites by the RAD17-RFC clamp loader; once loaded, the clamp recruits TopBP1 via CK2-phosphorylated Ser-341/Ser-387 in the RAD9 C-terminal tail, which in turn activates the ATR-ATRIP kinase complex to phosphorylate CHK1, driving S-phase and G2/M checkpoints; additionally, RAD9 acts as a scaffold/adaptor that directly stimulates multiple base-excision repair enzymes (FEN1, APE1, Pol β, NEIL1, TDG, MYH), participates in homologous recombination and mismatch repair (via MLH1), undergoes regulatory phosphorylation by PKCδ, c-Abl (Tyr-28), TLK1 (Ser-328/Thr-355), and is cleaved by caspase-3 to release a pro-apoptotic BH3-containing N-terminal fragment that antagonizes BCL-2/BCL-xL; chromatin recruitment is governed by Dot1-methylated H3K79 binding via the Tudor domain and phospho-H2AX recognition by the BRCT domains.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RAD9A encodes the RAD9 subunit of the heterotrimeric 9-1-1 (RAD9-HUS1-RAD1) DNA-damage clamp and is a core sensor/transducer of the DNA damage checkpoint, originally defined in budding yeast as essential for cell-cycle arrest in G1, S, and G2 after genotoxic insult [#0, #3, #6]. RAD9, RAD1, and HUS1 assemble into a toroidal heterotrimeric ring structurally indistinguishable from the PCNA sliding clamp [#20, #48], which is recruited onto RPA-coated damage sites by the RAD17-RFC clamp loader [#18, #34]. Once loaded on chromatin\\u2014a proximal, kinase-independent event [#22]\\u2014the clamp localizes the ATR-activating domain of TopBP1 through direct binding of CK2-phosphorylated RAD9 C-terminal residues (Ser-341/Ser-387, and Ser-373 in Xenopus), driving ATR-dependent CHK1 activation and S/G2 checkpoint arrest [#38, #39, #50, #51]. In yeast the orthologous Rad9 acts as a phospho-dependent signaling adaptor that, after Mec1/Tel1 phosphorylation at S/TQ motifs, engages the Rad53 FHA domain to enable Rad53 activation [#7, #8, #15, #19, #33]; its chromatin recruitment is governed by the Tudor domain binding Dot1-methylated H3K79 and the BRCT domains recognizing phospho-H2A/oligomerizing RAD9 [#11, #32, #40, #41]. Beyond checkpoint signaling, the 9-1-1 clamp directly stimulates multiple base-excision-repair enzymes including FEN1, Pol \\u03b2, APE1, NEIL1, and TDG [#26, #27, #36, #42, #43], and RAD9 contributes to homologous recombination, telomere maintenance, and mismatch repair through interactions with RAD51, telomerase, and MLH1 [#35, #37, #47]. RAD9 also has a pro-apoptotic function: it binds and antagonizes BCL-2/BCL-xL, and caspase-3 cleavage releases a BH3-containing N-terminal fragment that translocates to the cytosol to promote apoptosis [#14, #64]. Genetic deletion of mouse Rad9 causes midgestation embryonic lethality, genomic instability, and hypersensitivity to genotoxins, establishing its essential role in genome maintenance [#31].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Established that RAD9 is required for cell-cycle arrest after DNA damage, defining the existence of a damage checkpoint dependent on a dedicated gene rather than the repair machinery itself.\",\n      \"evidence\": \"Genetic analysis of rad9 mutants with X-irradiation and cell cycle analysis in S. cerevisiae\",\n      \"pmids\": [\"3291120\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No molecular function or biochemical activity assigned\", \"Checkpoint mechanism downstream of RAD9 unknown\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Extended RAD9 checkpoint function to G1/S and S-phase and placed it genetically with RAD17/RAD24 upstream of MEC1/RAD53, mapping its position in the checkpoint hierarchy.\",\n      \"evidence\": \"Genetic epistasis, cell-cycle synchronization, and double-mutant analysis across radiation conditions in yeast\",\n      \"pmids\": [\"8514150\", \"8367452\", \"9017389\", \"9564050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical nature of the signal transduced unknown\", \"Did not establish whether RAD9 acts as enzyme, adaptor, or structural component\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Showed RAD9 controls a damage-induced transcriptional regulon and defines a sensory branch parallel to Pol epsilon, broadening its role beyond simple cell-cycle arrest.\",\n      \"evidence\": \"Northern blots, lacZ reporters, and genetic epistasis with Rad53 phosphorylation readouts in yeast deletion mutants\",\n      \"pmids\": [\"8670896\", \"8895664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking RAD9 to transcription not resolved\", \"Direct vs indirect transcriptional role unclear\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identified RAD9 as a phospho-dependent adaptor: damage-induced Mec1/Tel1 hyperphosphorylation of Rad9 creates an FHA-domain docking site for Rad53, defining the molecular link between sensor and effector kinase.\",\n      \"evidence\": \"Phosphatase treatment, co-IP, FHA domain mutagenesis, and checkpoint functional assays in yeast\",\n      \"pmids\": [\"9755168\", \"9657725\", \"9564050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphosites not yet mapped\", \"Structural basis of FHA recognition not yet defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrated that human RAD9, RAD1, and HUS1 form a damage-responsive heterotrimeric complex and that the Rad9 BRCT domain mediates phospho-dependent oligomerization required for checkpoint function.\",\n      \"evidence\": \"Co-IP of human proteins, two-hybrid, BRCT point mutagenesis, and checkpoint survival assays\",\n      \"pmids\": [\"9872989\", \"10339432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Architecture of the complex unknown\", \"Whether complex resembled a clamp not yet shown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Predicted and began testing that 9-1-1 is a PCNA-like sliding clamp loaded by an RFC-like RAD17, reframing RAD9 as a structural DNA-binding clamp subunit; concurrently linked human RAD9 to apoptosis via BCL-2/BCL-xL.\",\n      \"evidence\": \"Computational fold recognition, fission-yeast complex co-IP/localization, NMR of Rad53 FHA1 with Rad9 phosphopeptide, and two-hybrid/co-IP with apoptosis assays\",\n      \"pmids\": [\"10871397\", \"10648611\", \"11124038\", \"10620799\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Clamp model still computational/inferred at this stage\", \"Mechanism of apoptotic function not yet defined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Reconstituted Rad9 as a scaffold catalyzing Rad53 activation in trans and confirmed PCNA-like structure-function features, distinguishing damage-specific from undamaged Rad9 complexes.\",\n      \"evidence\": \"Gel filtration, co-IP, in vitro kinase reconstitution, and structure-function mutagenesis in budding and fission yeast\",\n      \"pmids\": [\"11511366\", \"11739777\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reconciliation of scaffold vs adaptor models not yet settled\", \"Loading mechanism onto DNA not directly visualized\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined chromatin loading as a proximal, kinase-independent event mediated by RAD17 recruitment of 9-1-1, mapped Mec1/Tel1 SQ phosphosites selectively required for the Rad53 branch, and directly visualized the 9-1-1 ring by EM as PCNA-like.\",\n      \"evidence\": \"Chromatin fractionation with PIKK inhibitors, SQ-site mutagenesis with FHA pulldowns, and EM of baculovirus-reconstituted human 9-1-1 and Rad17-RFC\",\n      \"pmids\": [\"11799063\", \"12049741\", \"12167163\", \"12228248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How RPA directs loading not yet established\", \"Atomic structure of clamp not yet available\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Connected RAD9 to apoptotic signaling kinases, showing c-Abl phosphorylates Rad9 Tyr-28 in its BH3 domain to promote BCL-xL binding, linking the checkpoint protein to genotoxic cell-death decisions.\",\n      \"evidence\": \"Co-IP, in vitro kinase assays, Tyr-28 mutagenesis, and apoptosis assays in mammalian cells\",\n      \"pmids\": [\"11971963\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of apoptotic vs checkpoint role unclear\", \"Single-lab phosphosite assignment\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified PKC\\u03b4 as a regulator of 9-1-1 assembly and Rad9-BCL-2 binding, and showed caspase-3 cleavage liberates a pro-apoptotic BH3 N-terminal fragment, establishing post-translational control of RAD9's life/death function.\",\n      \"evidence\": \"Co-IP, in vitro kinase and caspase cleavage assays, cleavage-resistant mutants, and apoptosis assays in caspase-3-deficient cells\",\n      \"pmids\": [\"12628935\", \"14508514\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological balance between cleaved and intact RAD9 pools unquantified\", \"In vivo significance of apoptotic fragment not tested in animals\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated that RAD9 C-terminal tail phosphorylation drives CHK1 activation and replication-stress survival, separating the CHK1 branch determinants in the mammalian protein.\",\n      \"evidence\": \"Systematic phosphosite mutagenesis with complementation of Mrad9-/- ES cells and checkpoint assays across UV/IR/HU\",\n      \"pmids\": [\"12709442\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the kinase(s) phosphorylating the tail not yet defined\", \"Downstream effector recruited by phospho-tail unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Established that the 9-1-1 clamp directly stimulates base-excision-repair enzymes (Pol \\u03b2, FEN1), revealing a repair-promoting scaffold function distinct from PCNA and from checkpoint signaling.\",\n      \"evidence\": \"In vitro pulldowns and polymerase/nuclease activity assays with specificity controls across multiple polymerases\",\n      \"pmids\": [\"15314187\", \"15556996\", \"15184659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BER stimulation occurs in vivo at lesions not directly shown\", \"Coordination with checkpoint loading unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Genetically separated the Rad53 and Chk1 activation functions of yeast Rad9 into distinct domains, mapped Mec1-driven Rad9 accumulation at DSBs by ChIP, and showed mouse Rad9 is essential for embryonic viability and genome stability.\",\n      \"evidence\": \"Domain deletion with kinase readouts, ChIP with SQ mutagenesis, and targeted Mrad9 deletion with survival/mutation/complementation assays\",\n      \"pmids\": [\"14709724\", \"15060150\", \"15282322\", \"14988409\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism distinguishing Chk1 vs Rad53 branch recruitment incomplete\", \"Cause of embryonic lethality not resolved to a single pathway\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the chromatin-recruitment code for Rad9 via Dot1-methylated H3K79 binding by the Tudor domain and RPA interaction in human cells, and clarified the adaptor mechanism enabling Mec1 to phosphorylate Rad53.\",\n      \"evidence\": \"Checkpoint assays in dot1\\u0394/H3K79 mutants with Tudor mutagenesis, biochemical reconstitution with mass-spec phosphomapping, and co-IP/siRNA/chromatin fractionation for RPA\",\n      \"pmids\": [\"16166626\", \"16085488\", \"15897895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of histone marks vs RPA to recruitment not fully partitioned\", \"Human RPA-binding interface not yet mapped at residue level\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extended RAD9/9-1-1 function to homologous recombination, telomere maintenance, and additional BER glycosylase stimulation, broadening the clamp's genome-maintenance roles.\",\n      \"evidence\": \"Co-IP with Rad51 and telomerase, HR and telomere FISH assays, and in vitro NEIL1 glycosylase stimulation with co-localization\",\n      \"pmids\": [\"16479004\", \"16890531\", \"17395641\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect role in HR/telomere not fully dissected\", \"Single-lab functional assignments\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved the central mechanism of CHK1 activation: 9-1-1 recruits TopBP1 via phospho-Rad9 C-terminal residues to localize the ATR-activating domain, with TopBP1 bypass by AD-PCNA/H2B fusions proving the clamp's role is positional.\",\n      \"evidence\": \"Co-IP, domain-fusion bypass, phosphosite (Ser-373) mutagenesis, and CHK1 phosphorylation assays in human cells and Xenopus extracts\",\n      \"pmids\": [\"17575048\", \"17636252\", \"17721446\", \"17243194\", \"17855402\", \"17426133\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase identity for the key C-terminal site not yet pinned (resolved later)\", \"Stoichiometry of clamp:TopBP1:ATR not determined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified the RAD9 checkpoint recruitment domain binding the RPA70 OB-fold, revealed a resection-limiting role through Dot1/H3K79me, and characterized TLK1 and MLH1 interactions linking RAD9 to repair and mismatch repair.\",\n      \"evidence\": \"Domain mutagenesis with focus/CHK1 assays, ssDNA quantification (QAOS) with genetic dissection, and in vitro kinase/MMR assays with point mutants\",\n      \"pmids\": [\"18936170\", \"18418382\", \"18940270\", \"18842633\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How resection control integrates with checkpoint signaling not fully resolved\", \"MMR contribution single-lab and not validated in vivo\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Solved the atomic structure of human 9-1-1, revealing a PCNA-like toroid with a single repair-enzyme-binding site competitively blocked by p21 and a FEN1 PIP-box docking on the Rad1 IDC loop.\",\n      \"evidence\": \"X-ray crystallography from two independent labs with biochemical competition assays, plus TLK1B end-joining/release assays\",\n      \"pmids\": [\"19446481\", \"19464297\", \"20021694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of DNA-bound or loaded clamp not captured\", \"How enzyme handoffs at the single site are ordered unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Mapped CK2 phosphorylation of Rad9 Ser-341/Ser-387 and the TopBP1 BRCT2 docking that enable ATR activation, and identified DDK and CDK1 phosphorylation events controlling Rad9 release and cell-cycle-restricted recruitment.\",\n      \"evidence\": \"In vitro kinase assays with mutagenesis and survival assays, TopBP1 crystal structure with phosphopeptide binding, and Dpb11/CDK1 mutagenesis with checkpoint assays in yeast\",\n      \"pmids\": [\"20724438\", \"20545769\", \"21095590\", \"20700441\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of multiple kinase inputs on Rad9 tail not quantified\", \"Dynamics of recruitment vs release in vivo incompletely characterized\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established the Dpb11-Mec1-Rad9 ternary complex requiring CDK1-generated docking sites and identified PRMT5 arginine methylation of RAD9 as a checkpoint regulator, refining how RAD9 phosphorylation by Mec1 is enabled and cell-cycle-gated.\",\n      \"evidence\": \"In vitro reconstitution of ternary complex with CDK1 phosphosite mutagenesis, and in vitro methylation assays with site mutagenesis and CHK1/checkpoint readouts\",\n      \"pmids\": [\"21946560\", \"21321020\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ternary complex model applies in mammals not shown\", \"PRMT5 methylation single-lab and human-only\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealed RAD9 as a negative regulator of DSB end resection by limiting Sgs1/Dna2 and retaining Mre11, identifying a counterbalancing role to its checkpoint-activating function in repair-pathway choice.\",\n      \"evidence\": \"ChIP at HO-induced DSBs with genetic epistasis and end-tethering/repair assays in yeast\",\n      \"pmids\": [\"25637499\", \"25569305\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Conservation of resection-limiting role in mammals not established\", \"Molecular basis for nuclease inhibition incomplete\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed checkpoint signaling is tuned by antagonists and division of labor: Slx4/Rtt107 and Sae2 limit Rad9-driven Rad53 hyperactivation, while Mrc1 and Rad9 control replication checkpoint phases through complementary mechanisms.\",\n      \"evidence\": \"Co-IP and ChIP with genetic epistasis, Rad53 phosphorylation kinetics, and DNA combing in yeast mutants\",\n      \"pmids\": [\"23160493\", \"30510002\", \"30158111\", \"25091155\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether these regulatory antagonists operate on mammalian RAD9A unknown\", \"Quantitative thresholds for checkpoint tuning not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple post-translational inputs (CK2, c-Abl, PKC\\u03b4, TLK1, CDK1, DDK, PRMT5, caspase-3) are integrated to switch RAD9A between checkpoint-activating, repair-promoting, resection-limiting, and pro-apoptotic states in human cells remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model integrating RAD9A's modifications and functional states in mammals\", \"Structure of the loaded, DNA-bound human 9-1-1 with partners not determined\", \"In vivo coordination of repair vs apoptotic decisions not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [8, 33, 38, 39]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [20, 48]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [25, 30]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [40, 41]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [26, 27, 43]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [13, 18, 22]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [18, 30, 34]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [64]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 3, 24, 38]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [26, 27, 43, 47]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [18, 38, 39]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [14, 64]}\n    ],\n    \"complexes\": [\n      \"9-1-1 (RAD9-HUS1-RAD1) clamp\"\n    ],\n    \"partners\": [\n      \"HUS1\",\n      \"RAD1\",\n      \"TOPBP1\",\n      \"RPA\",\n      \"BCL2L1\",\n      \"FEN1\",\n      \"MLH1\",\n      \"RAD51\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}